All posts by Adam Brinded

Cambridge and DSIT announce prestigious Spärck AI Scholarships to support next generation of AI leaders

University of Cambridge students walking into the Senate House for their graduation ceremony.
University of Cambridge students walking into the Senate House for their graduation ceremony.
Credit: University of Cambridge

The Department for Science, Innovation and Technology (DSIT) has today announced the launch of the Spärck AI Scholarships, a major new initiative to nurture the next generation of AI leaders, with Cambridge University proud to join as a founding partner.

We are delighted to be a founding partner in this ambitious initiative, which reflects a shared commitment to attracting exceptional talent and reinforcing the UK’s position as a home for world-class AI.Professor Deborah Prentice, University of Cambridge Vice-Chancellor,

The scholarships, aimed at exceptionally high-potential domestic and international students, will support study towards AI-related Masters degrees and provide an unparalleled package of benefits. Students will receive full tuition fees, a living stipend, and access to priority work placements with leading UK AI companies and government institutions.

The programme, which will open to its first cohort in the 2026/27 academic year, intends to enrol 100 scholars over its first four years. Scholars will be selected from the top 1% of AI talent worldwide, with applicants required to demonstrate academic excellence, leadership, and ambassadorial potential, alongside a STEM background.

Uniquely, the Spärck AI Scholarships will provide its students with priority access to work placements within UK-based AI companies and organisations, including the UK government’s AI Security Institute (AISI) and i.AI, their in-house AI incubator.

The scholarships are named in honour of Professor Karen Spärck Jones (1935–2007), a pioneering British computer scientist whose ground breaking work at Cambridge University laid the foundations for modern search engines and natural language processing. One of the most remarkable women in computer science, her seminal 1972 paper introduced the concept of inverse document frequency (IDF), a fundamental principle still central to information retrieval today.

Professor Deborah Prentice, University of Cambridge Vice-Chancellor, said: “Cambridge combines academic excellence with a dynamic, interdisciplinary AI community, from foundational research to real-world impact. We are delighted to be a founding partner in this ambitious initiative, which reflects a shared commitment to attracting exceptional talent and reinforcing the UK’s position as a home for world-class AI. We are especially proud that these scholarships are named after Karen Spärck Jones, a brilliant Cambridge computer scientist.”

A long-time valued member of the Cambridge community, Professor Spärck Jones was an undergraduate at Girton College (1953-1956), a Research Fellow at Newnham College (1965-1968), an Official Fellow of Darwin College (1968-1980) and a Fellow of Wolfson College (2000-2007).

She began her research career at the Cambridge Language Research Unit in the late 1950s and later taught for the MPhil in Computer Speech and Language Processing, on language systems, and for the Computer Science Tripos on information retrieval. She supervised many Cambridge PhD students across a wide range of topics and was a tireless advocate for women in computing, famously declaring: “I think it’s very important to get more women into computing. My slogan is: Computing is too important to be left to men.”

Her international influence was recognised by numerous awards, including the ACM SIGIR Salton Award, the BCS Lovelace Medal, and election as a Fellow of the British Academy (of which she was also Vice-President from 2000 to 2002) and the American Association for Artificial Intelligence.

The University of Cambridge is delighted to honour her legacy by co-founding this exciting new programme, which was formally announced today at London Tech Week.



The text in this work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Images, including our videos, are Copyright ©University of Cambridge and licensors/contributors as identified. All rights reserved. We make our image and video content available in a number of ways – on our main website under its Terms and conditions, and on a range of channels including social media that permit your use and sharing of our content under their respective Terms.

source: cam.ac.uk

Cambridge and Manchester partnership to boost UK innovation and growth gets government backing

Cambridge will join forces with Manchester as part of a pioneering collaboration to harness the combined strengths of both universities and cities – and boost innovation and growth for the whole of the UK

This pioneering initiative brings together the combined strengths of Cambridge and Manchester to create something that is truly groundbreaking.Professor Deborah Prentice, Vice-Chancellor

The Cambridge x Manchester Innovation Partnership – the first trans-UK innovation collaboration of its kind – will receive £4.8m of funding from Research England over three years, it has been announced. With further investment from the two universities, the total funding for the partnership will be £6m. The initiative aims to strengthen research networks, accelerate scale-up growth, drive private sector investment into R&D, and attract new foreign direct investment.

Led by the universities of Cambridge and Manchester, ‘CBG×MCR’ is supported by two mayoral combined authorities, city councils, key businesses (such as AZ, ARM, ROKU, and Microsoft), venture capitalists (Northern Gritstone and CIC), and angel investors (Cambridge and Manchester Angels).

As well as strengthening relations within and between the two cities, the partnership – fronted by Innovate Cambridge and Unit M – will pilot new approaches for delivering inclusive growth, providing insights to other cities, the wider higher education sector community, and local and national governments in the UK and internationally.

In the UK, collaboration has traditionally been focused on geographically proximate areas, such as Manchester-Liverpool, or Edinburgh-Glasgow. This new model of hyper-connected, place-to-place partnering – similar to those developed in the US’ Northeast Corridor, Coastal California, and China’s Greater Bay Area – combines complementary innovation capabilities to create globally competitive connected ecosystems.

Amplifying what each city can achieve independently, the model aims to drive national economic growth, responding directly to the UK government’s national industrial strategy.

Professor Deborah Prentice, Vice-Chancellor of the University of Cambridge, said: “This pioneering initiative brings together the combined strengths of Cambridge and Manchester to create something that is truly groundbreaking. By connecting our cities, we’re helping to build a more collaborative and dynamic environment in which innovative research can connect with industry, venture capital, and entrepreneurs, to drive economic growth and deliver real benefits for people and places across the UK.”

Paul Bristow, Mayor of Cambridgeshire and Peterborough, said: “This is exactly the kind of partnership working we need to fire up innovation-led growth in both our regions. I’m delighted to see it backed with new funding. By joining forces to drive the discoveries of tomorrow, we can bring in investment, support exciting new businesses, and deliver real jobs and opportunity for our communities.”

Professor Duncan Ivison, President and Vice-Chancellor at the University of Manchester, said: “Our partnership with Cambridge marks a new model of collaboration between UK universities. It brings together the distinctive strengths of each of our universities and cities, connecting two of the great innovation ecosystems to scale up what we can achieve. This new approach to innovation accelerates the time between discovery and impact, getting ideas into the real economy and our communities even more quickly to drive inclusive growth.”

Jessica Corner, Executive Chair of Research England, said: “This investment underscores our commitment to fostering innovation and collaboration across England. By connecting the vibrant ecosystems of Cambridge and Manchester, we aim to drive significant economic growth and create a model for place-based innovation that can be replicated nationwide.”



The text in this work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Images, including our videos, are Copyright ©University of Cambridge and licensors/contributors as identified. All rights reserved. We make our image and video content available in a number of ways – on our main website under its Terms and conditions, and on a range of channels including social media that permit your use and sharing of our content under their respective Terms.

source: cam.ac.uk

Whistleblowing tech based on Cambridge research launched by the Guardian

Illustration of a whistleblower in crowd
Illustration of a whistleblower in crowd
Credit: Nanzeeba Ibnat via Getty Images

Whistleblowers can contact journalists more securely thanks to a new confidential and anonymous messaging technology co-developed by University of Cambridge researchers and software engineers at the Guardian.

The Guardian has launched Secure Messaging as a module within its mobile news app to provide a secure and usable method of establishing initial contact between journalists and sources.

It builds on a technology – CoverDrop –developed by Cambridge researchers and includes a wide range of security features. The code is available online and is open source, to encourage adoption by other news organisations.

The app automatically generates regular decoy messages to the Guardian to create ‘air cover’ for genuine messages, even when they are passing through the cloud, preventing an adversary from finding out if any communication between a whistleblower and a journalist is taking place.

“This provides whistleblowers with plausible deniability,” said Professor Alastair Beresford from Cambridge’s Department of Computer Science and Technology.

“That’s important in a world of pervasive surveillance where it has become increasingly hazardous to be a whistleblower,” said Cambridge’s Dr Daniel Hugenroth, who co-led the development of CoverDrop with Beresford.

The technology also provides digital ‘dead drops’ – like virtual bins or park benches – where messages are left for journalists to retrieve. These are just two of a suite of functions that protect a source from discovery even if their smartphone is seized or stolen.

CoverDrop encrypts outgoing messages between the source and their named contact at the news organisation to ensure no other party can read their content. For this, it relies on cryptography using digital security key pairs consisting of a public and a secret key.

The source is given the public key that instructs the existing encryption technology on their smartphone to encrypt their messages to the Guardian. This key only works one way, so it can lock – but not unlock – their messages. The only person able to decode them is the whistleblower’s named contact at the Guardian, who uses their secret key to retrieve and decode the messages left in the dead drop.

CoverDrop also pads all messages to the same length, making it harder for adversaries – whether acting on their own behalf or for an organisation or state – to distinguish real messages from decoy ones. 

The system fulfils a need long identified by media organisations: providing a highly secure, yet easy-to-use, system for potential sources who want to contact them with sensitive information.

“The Guardian is committed to public-interest journalism,” said Luke Hoyland, product manager for investigations and reporting at The Guardian. “Much of this is possible thanks to first-hand accounts from witnesses to wrongdoing. We believe whistleblowing is an important part of a functioning democracy and will always do our utmost to avoid putting sources at risk. So we’re delighted to have worked with the University of Cambridge on turning their groundbreaking CoverDrop research into a reality.”

The research began with workshops with UK news organisations to find out how potential sources first contacted them. The researchers learned that whistleblowers often reach out to them via platforms that are either insecure or hard to use.

Beresford said that when they started looking for a practical solution to this problem, “we realised that news organisations already run a widely available platform from which they can offer a secure, usable method of initial contact – their mobile news app.”

“When sources send messages, their confidentiality and integrity can be assured through the secure messaging protocols on their smartphone,” said Hugenroth. “CoverDrop goes one step further and also protects the communication patterns between sources and journalists by using decoy messages to provide cover and padding all messages to the same length.”

Importantly, the researchers say, users of the new CoverDrop system won’t need to install any specialist software that chews up large amounts of battery power or slows down their phones.

Its simple interface looks and works just like a typical messaging app. And there are no traces left on the device that the CoverDrop system has ever been used on that phone before.

“When you open the app,” said Beresford, “even if you’ve already set up an account on it, the CoverDrop feature will look as though you haven’t used it. Its home screen will only offer two prompts – ‘Get started’ or ‘Check your message vault’. This is because if it’s stolen, or a user is under duress, we don’t want your phone to reveal to anyone that you’ve already used it.”

The development of CoverDrop began in the years after the whistleblower Edward Snowden, a former US intelligence contractor, leaked classified documents revealing the existence of global surveillance programmes.

This showed, the researchers said, the mass surveillance infrastructure available to nation states, which has profound implications for those who wish to expose wrongdoing within companies, organisations, and government.

Work on CoverDrop was first unveiled at an international Symposium on Privacy-Enhancing Technologies in 2022 by the Cambridge researchers (who originally included the late Professor Ross Anderson, a leader in security engineering and privacy).

When they published their peer-reviewed paper on the research at the conference, it attracted interest from the Guardian which, in collaboration with the researchers, subsequently helped develop CoverDrop from an academic prototype into a fully usable technology.

“The free press fulfils an important function in a democracy,” said Beresford. “It can provide individuals with a mechanism through which they can hold powerful people and organisations to account. We’re delighted that the Guardian is the first media organisation to adopt CoverDrop and will use it to help protect their sources.”

“All the CoverDrop code will be available online and open source,” said Hugenroth. “This transparency is essential for security-critical software and allows others to audit and improve it. Open-sourcing the code also means that other news organisations, particularly those with expertise in investigative journalism, could also use it. We would be excited to see them do so.”

References:
Mansoor Ahmed-Rengers et al. ‘CoverDrop: Blowing the Whistle Through A News App.’ Paper presented at the Privacy Enhancing Technologies Symposium. 12 July 2022, Sydney, Australia. DOI: 10.2478/popets-2022-0035

A new technical report on CoverDrop, describing its architecture and explaining how it works, is available at: www.coverdrop.org/coverdrop_guardian_implementation_june_2025.pdf



The text in this work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Images, including our videos, are Copyright ©University of Cambridge and licensors/contributors as identified. All rights reserved. We make our image and video content available in a number of ways – on our main website under its Terms and conditions, and on a range of channels including social media that permit your use and sharing of our content under their respective Terms.

source: cam.ac.uk

Cambridge researcher awarded the Shaw Prize in Astronomy

John Richard Bond (left) and George Efstathiou (right)
John Richard Bond (left) and George Efstathiou (right)
Credit: Shaw Prize

Professor George Efstathiou has been awarded the Shaw Prize in Astronomy, one of the biggest prizes in the field.

Efstathiou, Emeritus Professor of Astrophysics (1909) at Cambridge’s Institute of Astronomy, shares the prize with Professor John Richard Bond from the Canadian Institute for Theoretical Astrophysics and the University of Toronto.

They were recognised for their pioneering research in cosmology, in particular for their studies of fluctuations in the cosmic microwave background. Their predictions have been verified by an armada of ground-, balloon- and space-based instruments, leading to precise determinations of the age, geometry, and mass-energy content of the universe.

Cosmology has undergone a revolution in the past two decades, driven mainly by increasingly precise measurements of the angular power spectrum of fluctuations in the temperature and polarisation fields of the cosmic microwave background, a relic of the early universe, most notably by NASA’s Wilkinson Microwave Anisotropy Probe spacecraft (2001–2010) and the European Space Agency’s Planck spacecraft (2009–2013).

These fluctuations are small — the strength of the background radiation is the same in all directions to better than 0.01% and it is only slightly polarised — but they offer a glimpse of the universe when it was very young, a test of many aspects of fundamental physics, insights into the nature of dark matter and dark energy, and measurements of many fundamental cosmological parameters with accuracies unimaginable to cosmologists a few decades ago.

Although many researchers contributed to the development of the theoretical framework that governs the behaviour of the cosmic microwave background, Bond and Efstathiou emphasised the importance of the background as a cosmological probe and took the crucial step of making precise predictions for what can be learned from specific models of the history and the composition of the mass and energy in the universe.

Modern numerical codes used to interpret the experimental results are based almost entirely on the physics developed by Bond and Efstathiou. Their work exemplifies one of the rare cases in astrophysics where later experimental studies accurately confirmed unambiguous, powerful theoretical predictions.

The interpretation of these experiments through Bond and Efstathiou’s theoretical models shows that the spatial geometry of the observable universe is nearly flat, and yields the age of the universe with a precision of 0.15%, the rate of expansion of the universe with a precision of 0.5%, the fraction of the critical density arising from dark energy to better than 1%, and so on. The measurements also strongly constrain theories of the early universe that might have provided the initial “seed” for all the cosmic structure we see today, and the nature of the dark matter and dark energy that dominate the mass-energy content of the universe.

Both Bond and Efstathiou have worked closely with experimentalists to bring their predictions to the test: they have been heavily involved in the analysis of cosmic microwave background data arising from a wide variety of experiments of growing sophistication and accuracy.

George Efstathiou received his BA in Physics from the University of Oxford and PhD in Astronomy from Durham University. He has held postdoctoral fellowships at the University of California, Berkeley, USA and the University of Cambridge. He was Savilian Professor of Astrophysics at Oxford, where he served as Head of Astrophysics until 1994. He returned to Cambridge in 1997 as Professor of Astrophysics, where he also served as Director of the Institute of Astronomy and the first Director of the Kavli Institute for Cosmology. He received the 2022 Gold Medal of the Royal Astronomical Society. He is a Fellow of the Royal Society of London and the Royal Astronomical Society, UK. He is a Fellow of King’s College, Cambridge.

Originally published on the Shaw Prize website. 



The text in this work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Images, including our videos, are Copyright ©University of Cambridge and licensors/contributors as identified. All rights reserved. We make our image and video content available in a number of ways – on our main website under its Terms and conditions, and on a range of channels including social media that permit your use and sharing of our content under their respective Terms.

source: cam.ac.uk

Cambridge celebrates historic Varsity Athletics competition and World Athletics recognition

The world’s oldest athletics competition — the annual contest between Cambridge and Oxford — reached a landmark celebration this year, commemorating 150 years of men’s competition, 50 years of women’s competition, and the second year of the para-athletics Varsity. 

First held in 1864, Varsity Athletics remains an enduring symbol of sporting excellence and tradition. This year’s event, hosted at Wilberforce Road Sports Ground in Cambridge, was made even more special by a prestigious recognition from World Athletics: the awarding of two Heritage Plaques to Cambridge University Athletic Club (CUAC) and the Varsity Match itself.

World Athletics Heritage Plaque

Founded in 1857, CUAC is one of the oldest athletics clubs in the world. It played a pivotal role in the development of modern athletics, contributing to the rules and formats that govern the sport today. “Cambridge University Athletic Club is among a small group of pioneering organisations that helped shape modern athletics,” World Athletics noted in its announcement.

In honour of this distinguished history, World Athletics CEO and Cambridge alumnus Jon Ridgeon (Magdalene College) returned to his alma mater to present the plaques during the Varsity weekend. 

Athletics Varsity 2025

Living up to the historic occasion, fierce but friendly rivalry was on display, with Cambridge securing victories in:

  • Men’s Blues
  • Para Team
  • Men’s 2nds
  • Women’s 2nds

In an interview with Varsity newspaper ahead of the Athletics Varsity, CUAC President Jess Poon reflected on the club’s evolution and the importance of the Varsity Matches. She highlighted the club’s embrace of inclusivity, particularly with the expansion of women’s and para-athletics matches, and celebrated the sense of tradition and camaraderie that continues to define the event.

Athletics Varsity plaque giving

This milestone celebration aligns closely with the University’s priority to encourage participation in sport and physical activity at all levels. Sport plays a critical role in supporting mental wellbeing, fostering leadership and communication skills, and enhancing employability among students.

Across the University, activity priorities include:

  • Club Support Programme: Aimed at helping sports clubs like CUAC deliver high-quality training and competition experiences, ensuring sustainability and growth.
  • University of Cambridge Athlete Performance Programme (UCAPP): Providing specialist support for high-performing athletes, enabling them to excel both in their sport and academically.
  • Active Students Initiative: Promoting sport and physical activity for all students, regardless of ability or experience level, through programmes like ‘Give it a Go’, designed to remove barriers and encourage lifelong engagement with physical activity.

Bhaskar Vira, Pro-Vice-Chancellor for Education and Chair of the Sports Committee, has expressed the University’s enthusiasm for supporting sport: “Involvement in physical activity and sports provides a much-needed release from the intense pressures that are associated with life at Cambridge. I firmly believe that these are inherently complementary pursuits, allowing participants to achieve a balance between their work commitments and their own personal wellbeing.”

The 150th Men’s, 50th Women’s, and 2nd Para Athletics Varsity Matches not only celebrated a rich and trailblazing past but also pointed towards a vibrant future, powered by a University-wide commitment to excellence, inclusion, and wellbeing in sport.

As Cambridge looks to build on this legacy, the University invites alumni and supporters to help sustain and grow these opportunities – ensuring that generations of Cambridge students continue to benefit from the profound personal, academic, and societal advantages that sport and physical activity bring.

Find out more information on how to support sport at Cambridge.

Varsity Athletics team



The text in this work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Images, including our videos, are Copyright ©University of Cambridge and licensors/contributors as identified. All rights reserved. We make our image and video content available in a number of ways – on our main website under its Terms and conditions, and on a range of channels including social media that permit your use and sharing of our content under their respective Terms.

source: cam.ac.uk

‘AI scientist’ suggests combinations of widely available non-cancer drugs can kill cancer cells

Scanning electron microscope image of breast cancer cells
Scanning electron microscope image of breast cancer cells
Credit: STEVE GSCHMEISSNER/SCIENCE PHOTO LIBRARY via Getty Images

An ‘AI scientist’, working in collaboration with human scientists, has found that combinations of cheap and safe drugs – used to treat conditions such as high cholesterol and alcohol dependence – could also be effective at treating cancer, a promising new approach to drug discovery.

The research team, led by the University of Cambridge, used the GPT-4 large language model (LLM) to identify hidden patterns buried in the mountains of scientific literature to identify potential new cancer drugs.

To test their approach, the researchers prompted GPT-4 to identify potential new drug combinations that could have a significant impact on a breast cancer cell line commonly used in medical research. They instructed it to avoid standard cancer drugs, identify drugs that would attack cancer cells while not harming healthy cells, and prioritise drugs that were affordable and approved by regulators.

The drug combinations suggested by GPT-4 were then tested by human scientists, both in combination and individually, to measure their effectiveness against breast cancer cells.

In the first lab-based test, three of the 12 drug combinations suggested by GPT-4 worked better than current breast cancer drugs. The LLM then learned from these tests and suggested a further four combinations, three of which also showed promising results.

The results, reported in the Journal of the Royal Society Interface, represent the first instance of a closed-loop system where experimental results guided an LLM, and LLM outputs – interpreted by human scientists – guided further experiments. The researchers say that tools such as LLMs are not a replacement for scientists, but could instead be supervised AI researchers, with the ability to originate, adapt and accelerate discovery in areas like cancer research.

Often, LLMs such as GPT-4 return results that aren’t true, known as hallucinations. However, in scientific research, hallucinations can sometimes be beneficial if they lead to new ideas that are worth testing.

“Supervised LLMs offer a scalable, imaginative layer of scientific exploration, and can help us as human scientists explore new paths that we hadn’t thought of before,” said Professor Ross King from Cambridge’s Department of Chemical Engineering and Biotechnology, who led the research. “This can be useful in areas such as drug discovery, where there are many thousands of compounds to search through.”

Based on the prompts provided by the human scientists, GPT-4 selected drugs based on the interplay between biological reasoning and hidden patterns in the scientific literature.

“This is not automation replacing scientists, but a new kind of collaboration,” said co-author Dr Hector Zenil from King’s College London. “Guided by expert prompts and experimental feedback, the AI functioned like a tireless research partner—rapidly navigating an immense hypothesis space and proposing ideas that would take humans alone far longer to reach.”

The hallucinations – normally viewed as flaws – became a feature, generating unconventional combinations worth testing and validating in the lab. The human scientists inspected the mechanistic reasons the LLM found to suggest these combinations in the first place, feeding the system back and forth in multiple iterations.

By exploring subtle synergies and overlooked pathways, GPT-4 helped identify six promising drug pairs, all tested through lab experiments. Among the combinations, simvastatin (commonly used to lower cholesterol) and disulfiram (used in alcohol dependence) stood out against breast cancer cells. Some of these combinations show potential for further research in therapeutic repurposing.

These drugs, while not traditionally associated with cancer care, could be potential cancer treatments, although they would first have to go through extensive clinical trials.

“This study demonstrates how AI can be woven directly into the iterative loop of scientific discovery, enabling adaptive, data-informed hypothesis generation and validation in real time,” said Zenil.

“The capacity of supervised LLMs to propose hypotheses across disciplines, incorporate prior results, and collaborate across iterations marks a new frontier in scientific research,” said King. “An AI scientist is no longer a metaphor without experimental validation: it can now be a collaborator in the scientific process.”

The research was supported in part by the Alice Wallenberg Foundation and the UK Engineering and Physical Sciences Research Council (EPSRC).

Find out more about how Cambridge is changing the story of cancer.

Reference:
Abbi Abdel-Rehim et al. ‘Scientific Hypothesis Generation by Large Language Models: Laboratory Validation in Breast Cancer Treatment.’ Journal of the Royal Society Interface (2025). DOI: 10.1098/rsif.2024.0674



The text in this work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Images, including our videos, are Copyright ©University of Cambridge and licensors/contributors as identified. All rights reserved. We make our image and video content available in a number of ways – on our main website under its Terms and conditions, and on a range of channels including social media that permit your use and sharing of our content under their respective Terms.

source: cam.ac.uk

Cambridge researchers awarded £7.5 million to build programmable plants

Gloved hand holding plant in pot
Gloved hand holding plant in pot
Credit: pkujiahe on Getty

Two groups involving researchers from the University of Cambridge’s Department of Plant Sciences are among nine teams to have been awarded funding today from the UK’s Advanced Research + Invention Agency (ARIA)’s Synthetic Plants programme.

We’re building the tools to make plants programmable, just like software. This isn’t science fiction – it’s the future of agriculture.Jake Harris

Imagine a plant with entirely new abilities – more nutritious food, crops that survive heatwaves, or leaves that grow useful materials. With new ARIA funding Cambridge researchers hope to unlock the technology to fast-track crop development and enhance plants with new qualities, like drought-tolerance to reduce the amount of water they need, or the ability to withstand pests and diseases.

Their research has the potential to revolutionise the future of agriculture and offer a radical new approach to securing food supply in the face of climate change.

Programmable plants – a major leap in plant biology

“We’re building the tools to make plants programmable, just like software. This isn’t science fiction – it’s the future of agriculture,” said Professor Jake Harris, Head of the Chromatin and Memory group, and project lead for one of the ARIA-funded projects.

Harris’ team is awarded £6.5 million to build the world’s first artificial plant chromosome.

The ambitious aim of the Synthetic Plants programme is to develop artificial chromosomes and chloroplasts that can survive in a living plant. If the teams achieve this, it will be one the most significant advances in plant synthetic biology.

The international team involves collaborators from The University of Western Australia, biotech company Phytoform Labs and the Australian Genome Foundry at Macquarie University.

“Our idea is that instead of modifying an existing chromosome, we design it from the ground up,” Professor Harris said.

He added: “We’re rethinking what plants can do for us. This synthetic chromosome could one day help grow crops that are more productive, more resilient, and better for the planet.”

While synthetic chromosomes have been achieved in simpler organisms, such as bacteria and yeast, this will be the first attempt to create and deploy one entirely from scratch in a plant.

The project will use the moss Physcomitrium patens – a unique, highly engineerable plant – as a development platform to build and test a bottom-up synthetic chromosome, before transferring it into potato plants.

It also opens new possibilities for growing food and medicines in space, and for indoor agriculture. It could allow scientists to give elite crop varieties disease resistance, or to grow productively in new climates and environments.

Unlocking powerful applications in agriculture

The second funded project, led by Professor Alison Smith and Dr Paweł Mordaka in the Plant Metabolism group, aims to use the synthetic chloroplasts to enable plants to fix nitrogen, and produce vitamin B12. The use of fertilisers to supply nitrogen and promote good crop yields is the greatest cause of pollution from agriculture; reducing the need for these would promote more sustainable food production systems.

This builds on their previous work to design and build the entire chloroplast genome for the simple single-cell alga Chlamydomonas reinhardtii.

The Cambridge researchers are awarded almost £1 million, as part of a £9 million grant to this project. They are working with an international team of researchers from the UK, USA and Germany to transfer this technology to build synthetic chloroplasts in potato plants.

Professor Smith said: “Our success would unlock powerful applications in agriculture, like plants capable of nitrogen fixation or producing essential nutrients like vitamin B12, potentially reducing fertiliser dependence and addressing malnutrition. These traits have tremendous potential should they be engineered into plants.”

She added: “It will enable scientists to surpass what can be accomplished with gene editing and equip plants with new functions, from reducing agricultural water use to protecting crop yields in uncertain conditions.”

A unique opportunity

The ambitiousness of this project is outside the scope of most other UK funding schemes. Professor Harris believes this stems from ARIA’s unique approach to developing the research opportunity and goal along with the research community.

Harris said: “ARIA had a couple of events with synthetic biologists to look at what’s on the edge of possible, what could be useful as a moonshot approach that could really change things.”

He added: “It’s a totally different way of seeing things. We went from ‘here’s what we want to see in the world’ to ‘how are we going to get there?’ It catalysed a different team and a different way of thinking.”

“This work moves us beyond the limitations of natural genomes. It’s about designing entirely new capabilities in plants – from the molecular level up.”

Currently, it typically takes eight years to develop a new crop variety in the UK, but with this new technology it could be a matter of one year or even less. The speed of development would be dramatically increased, much in the way that revolutionary protein-folding technology like AlphaFold has massively accelerated the process of drug discovery.

Synthetic biology is already revolutionising the world of healthcare and could transform agriculture if applied to tailoring plant traits.



The text in this work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Images, including our videos, are Copyright ©University of Cambridge and licensors/contributors as identified. All rights reserved. We make our image and video content available in a number of ways – on our main website under its Terms and conditions, and on a range of channels including social media that permit your use and sharing of our content under their respective Terms.

source: cam.ac.uk

Cambridge is the UK’s most innovation intensive city, says report

Hand holding test tubes in a lab

A new report by Dealroom shows that Cambridge is, for its size, the most innovative city in the UK. Globally, it ranks fourth behind US innovation powerhouses San Francisco, Boston and New York. 

Dealroom’s Global Tech Ecosystem Index analyses and compares start-up ecosystems in 288 cities across 69 countries. To measure innovation intensity, it looks for ecosystems that are performing well relative to their population size. These hubs typically have high start-up activity, research intensity and strong links with local universities.

Diarmuid O’Brien, Pro-Vice-Chancellor for Innovation at the University of Cambridge, said: “It’s great to see that, as a relatively small city, Cambridge continues to lead the UK in innovation intensity but it’s no accident that we punch above our weight. In recent years, the University and the wider ecosystem have put in place a range of initiatives to ensure that we realise our potential and are able to bring transformative science and technologies out of the lab and into the real world.”

Gerard Grech, Head of Founders at the University of Cambridge, which supports new ventures emerging from the University, added: “Cambridge is proof of what happens when world-class research meets relentless ambition. While global venture capital funding in 2024 pulled back, Cambridge doubled investment – a powerful signal that deep tech innovation is increasingly leading the way in shaping our future economies.

“What makes Cambridge unique is its cutting-edge science, an increasing flywheel of people who have successfully scaled ventures, and a culture built to turn ground-breaking ideas into transformative companies.”



The text in this work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Images, including our videos, are Copyright ©University of Cambridge and licensors/contributors as identified. All rights reserved. We make our image and video content available in a number of ways – on our main website under its Terms and conditions, and on a range of channels including social media that permit your use and sharing of our content under their respective Terms.

source: cam.ac.uk

Cambridge researchers named as 2025 Academy of Medical Sciences Fellows

Academy of Medical Sciences plaque
Academy of Medical Sciences plaque
Credit: Big T Images for Academy of Medical Sciences

Four Cambridge biomedical and health researchers are among those announced today as newly-elected Fellows of the Academy of Medical Sciences.

The new Fellows have been recognised for their remarkable contributions to advancing medical science, groundbreaking research discoveries and translating developments into benefits for patients and the wider public. Their work exemplifies the Academy’s mission to create an open and progressive research sector that improves health for everyone.

They join an esteemed Fellowship of 1,450 researchers who are at the heart of the Academy’s work, which includes nurturing the next generation of scientists and shaping research and health policy in the UK and worldwide.

One of Cambridge’s new Fellows, Professor Sam Behjati, is a former recipient of the Academy’s prestigious Foulkes Foundation medal, which recognises rising stars within biomedical research. Sam is Clinical Professor of Paediatric Oncology at the University and an Honorary Consultant Paediatric Oncologist at Addenbrooke’s Hospital, as well as Group Leader at the Wellcome Sanger Institute. His research is rooted in cancer genomics, phylogenetics, and single cell transcriptomics and spans a wide range of diseases and biological problems. More recently, his work has focused on the origin of cancers, in particular of childhood cancer. In addition, he explores how to use genomic data to improve the treatment of children. Sam is a Fellow at Corpus Christi College, Cambridge.

Also elected to the Academy of Medical Sciences Fellowship are:

Professor Clare Bryant, Departments of Medicine and Veterinary Medicine

Clare Bryant is Professor of Innate Immunity. She studies innate immune cell signalling during bacterial infection to answer fundamental questions about host-pathogen interactions and to search for new drugs to modify them. She also applies these approaches to study inflammatory signalling in chronic diseases of humans and animals.  Clare has extensive collaborations with many pharmaceutical companies, is on the scientific advisory board of several biotech companies, and helped found the natural product company Polypharmakos. Clare is a Fellow of Queens’ College, Cambridge.

Professor Frank Reimann, Institute of Metabolic Science-Metabolic Research Laboratories

Frank Reimann is Professor of Endocrine Signaling. The main focus of his group, run in close partnership with Fiona Gribble, is the enteroendocrine system within the gut, which helps regulate digestion, metabolism, and how full we feel. Their work has included the use of animal models and human cellular models to understand how cells function. One of these cells, glucagon-like peptide-1 (GLP-1) is the target of therapies now widely used in the treatment of diabetes mellitus and obesity. How cells shape feeding behaviour has become a major focus of the lab in recent years.

Professor Mina Ryten, UK Dementia Research Institute

Mina Ryten is a clinical geneticist and neuroscientist, and Director of the UK Dementia Research Institute at Cambridge since January 2024. She also holds the Van Geest Professorship and leads a lab focused on understanding molecular mechanisms driving neurodegeneration. Mina’s research looks at how genetic variation influences neurological diseases, particularly Lewy body disorders. Her work has advanced the use of single cell and long-read RNA sequencing to map disease pathways and identify potential targets for new treatments. Her expertise in clinical care and functional genomics has enabled her to bridge the gap between patient experience and scientific discovery.

Professor Andrew Morris CBE FRSE PMedSci, President of the Academy of Medical Sciences, said: “The breadth of disciplines represented in this year’s cohort – from mental health and infectious disease to cancer biology and respiratory medicine – reflects the rich diversity of medical science today. Their election comes at a crucial time when scientific excellence and collaboration across disciplines are essential for addressing global health challenges both now and in the future. We look forward to working with them to advance biomedical research and create an environment where the best science can flourish for the benefit of people everywhere.”

The new Fellows will be formally admitted to the Academy at a ceremony on Wednesday 9 July 2025.



The text in this work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Images, including our videos, are Copyright ©University of Cambridge and licensors/contributors as identified. All rights reserved. We make our image and video content available in a number of ways – on our main website under its Terms and conditions, and on a range of channels including social media that permit your use and sharing of our content under their respective Terms.

source: cam.ac.uk

Enhanced breast cancer screening in the UK could detect an extra 3,500 cancers per year, trial shows

Woman Undergoing Mammogram Procedure
Woman undergoing mammogram procedure – stock photo
Credit: Tom Werner (Getty Images)

Researchers in Cambridge are calling for additional scans to be added to breast screening for women with very dense breasts. This follows a large-scale trial, which shows that extra scans could treble cancer detection for these women, potentially saving up to 700 lives a year in the UK.

We need to change our national screening programme so we can make sure more cancers are diagnosed early, giving many more women a much better chance of survivalFiona Gilbert

Around 10% of women have very dense breasts. Between the ages of 50 and 70, these women are up to four-times more likely to develop breast cancer compared to women with low breast density.

Over 2.2 million women receive breast screening in the UK each year. For women with very dense breasts, mammograms (breast X-rays), which are used for breast screening, can be less effective at detecting cancer. This is because denser breasts look whiter on mammograms, which makes it harder to spot small early-stage cancers which also appear white.

Published today in The Lancet, a trial of over 9000 women across the UK who have dense breasts and had a negative (no cancer) mammogram result, found 85 cancers.

The trial, called BRAID, tested different scanning methods that could be used in addition to mammograms to detect cancers in dense breasts. Per 1000 women screened, two of the methods detected 17-19 cancers that were not seen in mammograms.

The two methods are known as CEM (contrast enhanced mammography) and AB-MRI (abbreviated magnetic resonance imaging).

The researchers that ran the trial recommend that adding either of these methods to existing breast screening could detect 3,500 more cancers per year in the UK. Estimates suggest that screening reduces mortality for about 20% of cancers detected, so this could mean an extra 700 lives saved each year.

BRAID also included a third scanning method, ABUS (automated whole breast ultrasound), which also detected cancers not seen in mammograms but was three times less effective than CEM and AB-MRI.

Each of the three methods was used to scan around 2000 women. Per 1000 women scanned, CEM detected 19 cancers, AB-MRI found 17 cancers, and ABUS found 4.

Mammograms already detect approximately 8 cancers per 1000 women with dense breasts. This means additional scans could more than treble breast cancer detection in this group of women.

BRAID is the first trial to directly compare supplemental imaging methods and to demonstrate their value for early cancer detection as part of widespread screening. The team hope their results will be used to enhance screening programmes in the UK and globally to diagnose more cancers early.

More work is needed to confirm whether additional scans will reduce the number of deaths as cancers detected through screening are not always life-threatening.

The trial was led from Cambridge. It recruited across 10 UK sites, including over 2000 women at Addenbrooke’s Hospital, Cambridge.

The research was led by Professor Fiona Gilbert, Department of Radiology, University of Cambridge and honorary consultant radiologist at Addenbrooke’s Hospital, part of Cambridge University Hospitals NHS Foundation Trust (CUH). The trial was funded by Cancer Research UK with support from the National Institute for Health and Care Research (NIHR) Cambridge Biomedical Research Centre (BRC).

Professor Gilbert said: “Getting a cancer diagnosis early makes a huge difference for patients in terms of their treatment and outlook. We need to change our national screening programme so we can make sure more cancers are diagnosed early, giving many more women a much better chance of survival.”

Professor Stephen Duffy, Emeritus Professor, Queen Mary University, London, trial statistician and screening programme expert said: “The NHS Breast Screening Programme has made a huge difference to many lives. Thanks to these results we can see that the technology exists to make screening even better, particularly for the 10% of women with dense breast tissue.”

Dr David Crosby, head of prevention and early detection at Cancer Research UK, said: “Breast cancer screening is for people without symptoms and helps to spot the disease at an early stage, when treatment is more likely to be successful. But having dense breasts can make it harder to detect cancer.

“This study shows that making blood vessels more visible during mammograms could make it much easier for doctors to spot signs of cancer in women with dense breasts. More research is needed to fully understand the effectiveness of these techniques, but these results are encouraging.

“Remember, having dense breasts is not something you can check for yourself or change, but if you’re concerned at all, you can speak to your GP.”

Reference
Gilbert, FJ et al. Comparison of supplemental imaging techniques – interim results of BRAID (Breast Screening: risk adapted imaging for density) randomized controlled trial. Lancet; 22 May 2025; DOI: 10.1016/S0140-6736(25)00582-3 

Press release from Cambridge University Hospitals NHS Foundation Trust


Louise’s story

Louise Duffield, age 60, a grandmother of four from Ely was diagnosed with early-stage breast cancer as a result of the BRAID trial.

Louise works in local government. She spends her free time knitting, and visiting 1940s events around the UK with her husband, Fred, and their two restored wartime Jeep. She is enthusiastic about clinical research and has previously participated as a healthy participant in several studies.

In 2023, Louise was invited to participate in the BRAID trial following her regular mammogram screening, which showed that she had very dense breasts. As part of the trial, Louise had an AB-MRI scan which identified a small lump deep inside one of her breasts.

“When they rang to say they’d found something, it was a big shock. You start thinking all sorts of things but, in the end, I just thought, at least if they’ve found something, they’ve found it early. The staff were brilliant, and so supportive.”

Soon after the MRI, Louise had a biopsy that confirmed she had stage 0 (very early) breast cancer within the ducts of one of her breasts. Six weeks later Louise underwent surgery to remove the tumour, during that time the tumour had already grown larger than it appeared on the scans.

“It’s been a stressful time and it’s a huge relief to have it gone. The team have been fantastic throughout. The tumour was deep in the breast so, if I hadn’t been on the trial, it could have gone unnoticed for years.

“I feel very lucky, it almost doesn’t feel like I’ve really had cancer. Without this research I could have had a very different experience.”

The location of Louise’s tumour meant it would have been difficult for her to find it through self-examination, and since it was not detected during her regular mammogram it would have been at least three years before she was invited for another.

Following a short course of radiotherapy, Louise is now cancer free. She will continue to be monitored for several years and will continue to be attending her regular mammograms every three years as part of the national breast cancer screening programme.

“This experience has highlighted to me how important screening is. If I hadn’t had the mammogram, I wouldn’t have been invited to the trial. Getting treated was so quick because they found the cancer early.”



The text in this work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Images, including our videos, are Copyright ©University of Cambridge and licensors/contributors as identified. All rights reserved. We make our image and video content available in a number of ways – on our main website under its Terms and conditions, and on a range of channels including social media that permit your use and sharing of our content under their respective Terms.

source: cam.ac.uk

Life, death and mowing

Britain’s poetic obsession with the humble lawnmower revealed and explained

By Tom Almeroth-Williams

Over the last half-century, British poets including Philip Larkin and Andrew Motion have driven a ‘lawnmower poetry microgenre’, using the machine to explore childhood, masculinity, violence, addiction, mortality and much more, new research shows.

The study, published in Critical Quarterly, argues that the tradition goes back to the 17th-century poet Andrew Marvell who used mowing – with a scythe – to comment on the violence of the English Civil War.

“Lawnmower poetry had its highpoint in the late 20th century but now would be a good moment for a revival,” says the study’s author, Francesca Gardner, from Cambridge’s English Faculty and St Catharine’s College.

“It might seem random to write poetry about mowing but it’s a great vehicle for exploring our relationship with nature and with each other. Andrew Marvell wrote about mowing with scythes after the English Civil War and modern poets continue to use lawnmowers to think about their own ups and downs.

“In a time of eco-crisis, conflict and societal problems, perhaps another poet will be inspired to write one soon. They might reflect the growing anti-lawn movement or something else entirely.”

In 1651, Andrew Marvell wrote a poem in which a mower accidentally kills a bird crouched in the grass. In ‘Upon Appleton House’, he wrote that the ‘Edge’ of the scythe was left ‘all bloody from its Breast’.

Gardner argues that the poem makes us think about ‘the Flesh untimely mow’d’ as a result of powerful undeviating cycles including the seasons and warfare which dominate our lives and determine our actions.

In 1979, another poet from Hull, Philip Larkin, described killing a hedgehog with his own motorised machine. In The MowerLarkin wrote that his mower had ‘stalled, twice’ and that he found ‘A hedgehog jammed up against the blades, / Killed.’

Inspired by ‘Upon Appleton House’, Larkin also admired Marvell’s four mower poems, ‘The Mower’s Song’, ‘Damon the Mower’, ‘The Mower Against Gardens’, and ‘The Mower to the Glow-Worms’, describing them as ‘charming and exquisite in the pastoral tradition’, and Gardner points out numerous similarities between the two poets.

“Larkin had a deep awareness of pastoral and georgic poetry and this makes his poem more unsettling. While he felt terrible about killing the hedgehog, which really happened, his poem is disturbing because it presents an uneasy affinity between the natural and the mechanical.”

“Every time Larkin cuts the grass, it grows back so he’s forced to use a machine that completes the job efficiently and repeatedly. By mirroring nature’s cruel, relentless forces, mowers like Larkin commit their own acts of cruelty and violence.”

And yet, Gardner argues, it is often through their violence that the human mowers in these poems discover a capacity to be careful, sensitive and empathetic.

Larkin’s is one the best-known lawnmower poems from the UK and USA discussed by Gardner but not the only one to tackle traumatic events.

In 2007, Andrew Motion based a moving elegy for his father on happy memories of him mowing the lawn. By contrast, Michael Laskey’s 1999 ‘The Lawnmower’ uses the machine to describe fatherly ‘despotism and neglect’, Gardner argues.

“Mowing a lawn is often viewed as a victory over nature but these poems reflect an increasing sense that this is a pyrrhic or ignoble victory,” Gardner says. “The father in Michael Laskey’s poem is so intent on mowing straight lines that he misses out on the joyful messiness of life with his children.”

Laskey’s poem ends: ‘We keep back, / do as we’re told, don’t touch. / It must be overgrown now, the grave’.

Gardner says: “British poets are very interested in the lawn as a nostalgic space so lawnmowers are often associated with childhood memories, especially of fathers working. The lawn is a safe domestic, often suburban, space in which unexpected violence can occur, as when Larkin kills a hedgehog.”

Gardner’s favourite lawnmower poem is Mark Waldron’s 2017 ‘I wish I loved lawnmowers’ which explores alienation, obsession and drug addiction. The speaker tells us that, if he loved lawnmowers, he would take a trip to the British Lawnmower Museum in Southport. But he doesn’t and the poem ends: ‘Now crack cocaine — that I loved’.

Most of the poems Gardner studied were written by recognised poets but she also found examples written by lawnmower enthusiasts. In 2013, Grassbox, the Old Lawnmower Club’s magazine, published Tony Hopwood’s parody of the hymn ‘Morning Has Broken’ which laments: ‘Mower has broken, / Gardener’s in mourning. / Missus has spoken, / Had the last word.’

“Lawnmowers draw people to poetry as much as poetry draws people to lawnmowers,” Gardner says.

Gardner points out that to-date most British lawnmower poems have been written by men but has found examples of women poking fun at mower-obsessed men. In 2002, Grassbox published ‘A Lawnmower Widow’s Lament’, a poem by Peggy Miller, which opens: ‘I once was loved and cherished by a man who was quite handsome / But now I’m second fiddle to a Dennis or Ransomes’.

Francesca Gardner, a Harding Distinguished Scholar, is an expert on early modern pastoral, georgic, and ‘nature’ writing. She explains that British and American lawnmower poetry is rooted in two forms of ancient nature poetry.

The pastoral form presents an idyllic form of nature in which shepherds stroll through fields and the land yields things up to them. By contrast, georgic poetry involves people having to work hard and use tools because nature isn’t so generous.

Gardner points out that Andrew Marvell’s ‘Upon Appleton House’ is an unusual mixture of both pastoral and georgic.

“Poets inspired by Marvell appreciate that clash between idyllic nature and what it takes to maintain the lawn as an ideal space, the georgic conception of work,” Gardner says.

The final lines of Larkin’s poem were widely quoted during the Covid-19 pandemic: ‘we should be kind / While there is still time.’

“That remains a useful lesson whether we’re mowing or not,” Gardner says.

Reference

Francesca Gardner, ‘Lawnmower Poetry and the Poetry of Lawnmowers’,
Critical Quarterly (2025). DOI: 10.1111/criq.12818

Find out more from Francesca in this short film:

Francesca Gardner on the lawn at St Catharine's College, Cambridge, in front of a lawnmower
Francesca Gardner at St Catharine’s College, Cambridge
Portrait of Andrew Marvell attributed to Godfrey Kneller in the collection of Marvell's alma mater, Trinity College, Cambridge
Portrait of Andrew Marvell attributed to Godfrey Kneller in the collection of his Marvell’s alma mater, Trinity College, Cambridge
Francis Place (1647-1728), A Study for the Pilkington Crest, a mower with a scythe (undated). Yale Center for British Art, Paul Mellon Collection
Francis Place (1647-1728), A mower with a scythe (undated)
A black and white photo of a man wearing a suit mowing a lawn
Photograph of a man mowing a lawn in the mid-20th Century
Horse-drawn mowing of the meadow at King's College, Cambridge
Mowing the meadow at King’s College, Cambridge in 2022

Published 17th May 2025

The text in this work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License


Image credits

University of Cambridge: Title image; Francesca Gardner
Sarah Laval via Flikr: mower in motion (banner)

Trinity College, Cambridge: Portrait of Andrew Marvell
Yale Center for British Art, Paul Mellon Collection: Mower with a scythe
Mike Finn via Flikr: Hedgehog
Dave’s Archive via Flikr: two archive photographs of men mowing
Lloyd Mann: Meadow mowing at King’s College, Cambridge

source: cam.ac.uk

Removing ovaries and fallopian tubes linked to lower risk of early death among certain breast cancer patients

Doctor and patient making a mammography
Doctor and patient making a mammography
Credit: pixelfit (Getty Images)

Women diagnosed with breast cancer who carry particular BRCA1 and BRCA2 genetic variants are offered surgery to remove the ovaries and fallopian tubes as this dramatically reduces their risk of ovarian cancer. Now, Cambridge researchers have shown that this procedure – known as bilateral salpingo-oophorectomy (BSO) – is associated with a substantial reduction in the risk of early death among these women, without any serious side-effects.

Our findings will be crucial for counselling women with cancer linked to one of the BRCA1 and BRCA2 variants, allowing them to make informed decisions about whether or not to opt for this operationAntonis Antoniou

Women with certain variants of the genes BRCA1 and BRCA2 have a high risk of developing ovarian and breast cancer. These women are recommended to have their ovaries and fallopian tubes removed at a relatively early age – between the ages 35 and 40 years for BRCA1 carriers, and between the ages 40 and 45 for BRCA2 carriers.

Previously, BSO has been shown to lead to an 80% reduction in the risk of developing ovarian cancer among these women, but there is concern that there may be unintended consequences as a result of the body’s main source of oestrogen being removed, which brings on early menopause. This can be especially challenging for BRCA1 and BRCA2 carriers with a history of breast cancer, as they may not typically receive hormone replacement therapy to manage symptoms. The overall impact of BSO in BRCA1 and BRCA2 carriers with a prior history of breast cancer remains uncertain. 

Ordinarily, researchers would assess the benefits and risks associated with BSO through randomised controlled trials, the ‘gold standard’ for testing how well treatments work. However, to do so in women who carry the BRCA1 and BRCA2 variants would be unethical as it would put them at substantially greater risk of developing ovarian cancer.

To work around this problem, a team at the University of Cambridge, in collaboration with the National Disease Registration Service (NDRS) in NHS England, turned to electronic health records and data from NHS genetic testing laboratories collected and curated by NDRS to examine the long-term outcomes of BSO among BRCA1 and BRCA2 PV carriers diagnosed with breast cancer. The results of their study, the first large-scale study of its kind, are published today in The Lancet Oncology.

The team identified a total of 3,400 women carrying one of the BRCA1 and BRCA2 cancer-causing variants (around 1,700 women for each variant). Around 850 of the BRCA1 carriers and 1,000 of the BRCA2 carriers had undergone BSO surgery.

Women who underwent BSO were around half as likely to die from cancer or any other cause over the follow-up period (a median follow-up time of 5.5 years). This reduction was more pronounced in BRCA2 carriers compared to BRCA1 carriers (a 56% reduction compared to 38% respectively). These women were also at around a 40% lower risk of developing a second cancer.

Although the team say it is impossible to say with 100% certainty that BSO causes this reduction in risk, they argue that the evidence points strongly towards this conclusion.

Importantly, the researchers found no link between BSO and increased risk of other long-term outcomes such as heart disease and stroke, or with depression. This is in contrast to previous studies that found evidence in the general population of an association between BSO and increased risk of these conditions.

First author Hend Hassan, a PhD student at the Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, and Wolfson College, Cambridge, said: “We know that removing the ovaries and fallopian tubes dramatically reduces the risk of ovarian cancer, but there’s been a question mark over the potential unintended consequences that might arise from the sudden onset of menopause that this causes.

“Reassuringly, our research has shown that for women with a personal history of breast cancer, this procedure brings clear benefits in terms of survival and a lower risk of other cancers without the adverse side effects such as heart conditions or depression.”

Most women undergoing BSO were white. Black and Asian women were around half as likely to have BSO compared to white women. Women who lived in less deprived areas were more likely to have BSO compared to those in the most-deprived category.

Hassan added: “Given the clear benefits that this procedure provides for at-risk women, it’s concerning that some groups of women are less likely to undergo it. We need to understand why this is and encourage uptake among these women.”

Professor Antonis Antoniou, from the Department of Public Health and Primary Care, the study’s senior author, said: “Our findings will be crucial for counselling women with cancer linked to one of the BRCA1 and BRCA2 variants, allowing them to make informed decisions about whether or not to opt for this operation.”

Professor Antoniou, who is also Director of the Cancer Data-Driven Detection programme, added: “The study also highlights the power of exceptional NHS datasets in driving impactful, clinically relevant research.”

The research was funded by Cancer Research UK, with additional support from the National Institute for Health and Care Research (NIHR) Cambridge Biomedical Research Centre.

The University of Cambridge is fundraising for a new hospital that will transform how we diagnose and treat cancer. Cambridge Cancer Research Hospital, a partnership with Cambridge University Hospitals NHS Foundation Trust, will treat patients across the East of England, but the research that takes place there promises to change the lives of cancer patients across the UK and beyond. Find out more here.

Reference

Hassan, H et al. Long-term health outcomes of bilateral salpingo-oophorectomy in BRCA1 and BRCA2 pathogenic variant carriers with personal history of breast cancer: a retrospective cohort study using linked electronic health records. Lancet Oncology; 7 May 2025; DOI: 10.1016/S1470-2045(25)00156-1



The text in this work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Images, including our videos, are Copyright ©University of Cambridge and licensors/contributors as identified. All rights reserved. We make our image and video content available in a number of ways – on our main website under its Terms and conditions, and on a range of channels including social media that permit your use and sharing of our content under their respective Terms.

source: cam.ac.uk

Significant gaps in NHS care for patients who are deaf or have hearing loss, study finds

A male doctor sits next to a male patient in a waiting room while holding a digital tablet. In the background a nurse chats to a family while holding digital tablet.
A male doctor sits next to a male patient in a waiting room while holding a digital tablet.
Credit: sturti via Getty Images

A majority of individuals who are deaf or have hearing loss face significant communication barriers when accessing care through the National Health Service (NHS), with nearly two-thirds of patients missing half or more of vital information shared during appointments.

Better communication for deaf patients benefits everyone. We’re not just pointing out problems – we’re providing practical solutions.Bhavisha Parmar

A team of patients, clinicians, researchers and charity representatives, led by the University of Cambridge and the British Society of Audiology, surveyed over 550 people who are deaf or have hearing loss about their experiences with the NHS – making it the largest study of its kind. Their findings, reported in the journal PLOS One, highlight systemic failures and suggest changes and recommendations for improving deaf-aware communication in the NHS.

“The real power of this study lies in the stories people shared,” said lead author Dr Bhavisha Parmar from Cambridge’s Department of Clinical Neurosciences (Sound Lab) and UCL Ear Institute. “Patients weren’t just rating their experiences – they were telling us how these barriers affect every part of their healthcare journey, and in many cases, why they avoid healthcare altogether.”

The study found that despite being a legal requirement under the Accessible Information Standards, NHS patients have inadequate and inconsistent access to British Sign Language (BSL) interpreters and other accessibility accommodations such as hearing loop systems.

Nearly two-thirds (64.4%) of respondents reported missing at least half of the important information during appointments, and only a third (32%) expressed satisfaction with NHS staff communication skills. Respondents said they had to rely on family members or advocates to communicate with healthcare workers, raising privacy and consent concerns.

The research found that communication barriers extend across the entire patient journey – from booking appointments to receiving results. Simple actions, like calling a patient’s name in a waiting room or giving instructions during a scan, become anxiety-inducing when basic accommodations are lacking. Respondents noted that hearing aids often must be removed for X-rays or MRI scans, leaving them struggling or unable to follow verbal instructions.

“We heard over and over that patients fear missing their name being called, or avoid making appointments altogether,” said Parmar. “These aren’t isolated experiences – this is a systemic issue.”

The idea for the study was sparked by real-life experiences shared online by NHS patients, particularly audiology patients– a field Parmar believes should lead by example. “We’re audiologists: we see more patients with hearing loss than anyone else in the NHS,” she said. “If we’re not deaf-aware, then how can we expect other parts of the NHS to be?”

The research team included NHS patients with deafness or hearing loss, who contributed to study design, data analysis, and report writing. As part of the study, they received training in research methods, ensuring the work was grounded in and reflective of lived experiences.

Co-author Zara Musker, current England Deaf Women’s futsal captain and winner of deaf sports personality of the year 2023 said her disappointing experiences with the NHS in part motivated her to qualify as an audiologist.

“The research is extremely important as I have faced my own experiences of inadequate access, and lack of deaf awareness in NHS healthcare not just in the appointment room but the whole process of booking appointments, being in the waiting room, interacting with clinicians and receiving important healthcare information,” said Musker. “I really hope that the results will really highlight that NHS services are still not meeting the needs of patients. Despite this, the study also highlights ways that the NHS can improve, and recommendations are suggested by those who face these barriers within healthcare.”

The researchers have also released a set of recommendations that could improve accessibility in the NHS, such as:

  • Mandatory deaf awareness and communication training for NHS staff
  • Consistent provision of interpreters and alert systems across all NHS sites
  • Infrastructure improvements, such as text-based appointment systems and visual waiting room alerts
  • The creation of walk-through assessments at hospitals to ensure accessibility across the full patient journey

“This is a legal obligation, not a luxury,” said Parmar. “No one should have to write down their symptoms in a GP appointment or worry they’ll miss their name being called in a waiting room. These are simple, solvable issues.”

A practice guidance resource – developed in consultation with patients and driven by this research – is open for feedback until 15 June and will be made publicly available as a free tool to help clinicians and NHS services improve deaf awareness. People can submit feedback at the British Society of Audiology website.

“Ultimately, better communication for deaf patients benefits everyone,” Parmar said. “We’re not just pointing out problems – we’re providing practical solutions.”

Reference:
Bhavisha Parmar et al. ‘“I always feel like I’m the first deaf person they have ever met.” Deaf Awareness, Accessibility and Communication in the United Kingdom’s National Health Service (NHS): How can we do better?’ PLOS One (2025). DOI: 10.1371/journal.pone.0322850

https://youtube.com/watch?v=gEsEZDBsEQY%3Fsi%3Df76tEj_tJP2XKhzY


The text in this work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Images, including our videos, are Copyright ©University of Cambridge and licensors/contributors as identified. All rights reserved. We make our image and video content available in a number of ways – on our main website under its Terms and conditions, and on a range of channels including social media that permit your use and sharing of our content under their respective Terms.

source: cam.ac.uk

Adolescents with mental health conditions use social media differently than their peers, study suggests

Teenage boy with smart phone
Teenage boy with smart phone
Credit: D-Keine via Getty

One of the first studies in this area to use clinical-level diagnoses reveals a range of differences between young people with and without mental health conditions when it comes to social media – from changes in mood to time spent on sites.

Young people with a diagnosable mental health condition report differences in their experiences of social media compared to those without a condition, including greater dissatisfaction with online friend counts and more time spent on social media sites.

This is according to a new study led by the University of Cambridge, which suggests that adolescents with ‘internalising’ conditions such as anxiety and depression report feeling particularly affected by social media.

Young people with these conditions are more likely to report comparing themselves to others on social media, feeling a lack of self-control over time spent on the platforms, as well as changes in mood due to the likes and comments received.

Researchers found that adolescents with any mental health condition report spending more time on social media than those without a mental health condition, amounting to an average of roughly 50 minutes extra on a typical day.*

The study, led by Cambridge’s Medical Research Council Cognition and Brain Sciences Unit (MRC CBU), analysed data from a survey of 3,340 adolescents in the UK aged between 11 and 19 years old, conducted by NHS Digital in 2017.**

It is one of the first studies on social media use among adolescents to utilise multi-informant clinical assessments of mental health. These were produced by professional clinical raters interviewing young people, along with their parents and teachers in some cases.***

“The link between social media use and youth mental health is hotly debated, but hardly any studies look at young people already struggling with clinical-level mental health symptoms,” said Luisa Fassi, a researcher at Cambridge’s MRC CBU and lead author of the study, published in the journal Nature Human Behaviour.

“Our study doesn’t establish a causal link, but it does show that young people with mental health conditions use social media differently than young people without a condition.

“This could be because mental health conditions shape the way adolescents interact with online platforms, or perhaps social media use contributes to their symptoms. At this stage, we can’t say which comes first – only that these differences exist,” Fassi said.

The researchers developed high benchmarks for the study based on existing research into sleep, physical activity and mental health. Only findings with comparable levels of association to how sleep and exercise differ between people with and without mental health conditions were deemed significant.

While mental health was measured with clinical-level assessments, social media use came from questionnaires completed by study participants, who were not asked about specific platforms.****

As well as time spent on social media, all mental health conditions were linked to greater dissatisfaction with the number of online friends. “Friendships are crucial during adolescence as they shape identity development,” said Fassi.

“Social media platforms assign a concrete number to friendships, making social comparisons more conspicuous. For young people struggling with mental health conditions, this may increase existing feelings of rejection or inadequacy.”

Researchers looked at differences in social media use between young people with internalising conditions, such as anxiety, depression and PTSD, and externalising conditions, such as ADHD or conduct disorders.

The majority of differences in social media use were reported by young people with internalising conditions. For example, ‘social comparison’ – comparing themselves to others online – was twice as high in adolescents with internalising conditions (48%, around one in two) than for those without a mental health condition (24%, around one in four).

Adolescents with internalising conditions were also more likely to report mood changes in response to social media feedback (28%, around 1 in 4) compared to those without a mental health condition (13%, around 1 in 8). They also reported lower levels of self-control over time spent on social media and a reduced willingness to be honest about their emotional state when online.*****

“Some of the differences in how young people with anxiety and depression use social media reflect what we already know about their offline experiences. Social comparison is a well-documented part of everyday life for these young people, and our study shows that this pattern extends to their online world as well,” Fassi said.

By contrast, other than time spent on social media, researchers found few differences between young people with externalising conditions and those without a condition.

“Our findings provide important insights for clinical practice, and could help to inform future guidelines for early intervention,” said Cambridge’s Dr Amy Orben, senior author of the study.

“However, this study has only scratched the surface of the complex interplay between social media use and mental health. The fact that this is one of the first large-scale and high-quality studies of its kind shows the lack of systemic investment in this space.”

Added Fassi: “So many factors can be behind why someone develops a mental health condition, and it’s very hard to get at whether social media use is one of them.”

“A huge question like this needs lots of research that combines experimental designs with objective social media data on what young people are actually seeing and doing online.”

“We need to understand how different types of social media content and activities affect young people with a range of mental health conditions such as those living with eating disorders, ADHD, or depression. Without including these understudied groups, we risk missing the full picture.”

Notes:

*Study participants were asked to rate their social media use on a typical school day and a typical weekend or holiday day. This was given as a nine-point scale, ranging from less than 30 minutes to over seven hours. Responses from adolescents with any mental health condition approached on average ‘three to four hours’, compared to adolescents without a condition, who averaged between ‘one to two hours’ and ‘two to three hours’.

The category of all mental health conditions in the study includes several conditions that are classed as neither internalising or externalising, such as sleep disorders and psychosis. However, the numbers of adolescents suffering from these are comparatively small.

**The survey was conducted as part of NHS Digital’s Mental Health of Children and Young People Survey (MHCYP) and is nationally representative of this age group in the UK. The researchers only used data from those who provided answers on social media use (50% male, 50% female).

*** Previous studies have mainly used self-reported questionnaires (e.g. a depression severity questionnaire) to capture mental health symptoms and conditions in participants.

**** The researchers point out that, as responses on social media use were self-reported, those with mental health conditions may be perceiving they spend more time on social media rather than actually doing so. They say that further research with objective data is required to provide definitive answers.

***** For data on social media use, study participants were asked to rate the extent to which they agree with a series of statements on a five-point Likert scale. The statements ranged from ‘I compare myself to others on social media’ to ‘I am happy with the number of friends I have on social media’.

Researchers divided responses into ‘disagree’ (responses 1 to 3) and ‘agree’ (responses 4 and 5) and then calculated the proportion of adolescents agreeing separately for each diagnostic group to aid with public communication of the findings.



The text in this work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Images, including our videos, are Copyright ©University of Cambridge and licensors/contributors as identified. All rights reserved. We make our image and video content available in a number of ways – on our main website under its Terms and conditions, and on a range of channels including social media that permit your use and sharing of our content under their respective Terms.

source: cam.ac.uk

Adolescents who sleep longer perform better at cognitive tasks

Teenager asleep and wrapped in a blanket
Teenager asleep and wrapped in a blanket
Credit: harpazo_hope (Getty Images)

Adolescents who sleep for longer – and from an earlier bedtime – than their peers tend to have improved brain function and perform better at cognitive tests, researchers from the UK and China have shown.

Even though the differences in the amount of sleep that each group got was relatively small, we could still see differences in brain structure and activity and in how well they did at tasks
Barbara Sahakian

But the study of adolescents in the US also showed that even those with better sleeping habits were not reaching the amount of sleep recommended for their age group.

Sleep plays an important role in helping our bodies function. It is thought that while we are asleep, toxins that have built up in our brains are cleared out, and brain connections are consolidated and pruned, enhancing memory, learning, and problem-solving skills. Sleep has also been shown to boost our immune systems and improve our mental health.

During adolescence, our sleep patterns change. We tend to start going to bed later and sleeping less, which affects our body clocks. All of this coincides with a period of important development in our brain function and cognitive development. The American Academy of Sleep Medicine says that the ideal amount of sleep during this period is between eight- and 10-hours’ sleep.

Professor Barbara Sahakian from the Department of Psychiatry at the University of Cambridge said: “Regularly getting a good night’s sleep is important in helping us function properly, but while we know a lot about sleep in adulthood and later life, we know surprisingly little about sleep in adolescence, even though this is a crucial time in our development. How long do young people sleep for, for example, and what impact does this have on their brain function and cognitive performance?”

Studies looking at how much sleep adolescents get usually rely on self-reporting, which can be inaccurate. To get around this, a team led by researchers at Fudan University, Shanghai, and the University of Cambridge turned to data from the Adolescent Brain Cognitive Development (ABCD) Study, the largest long-term study of brain development and child health in the United States.

As part of the ABCD Study, more than 3,200 adolescents aged 11-12 years old had been given FitBits, allowing the researchers to look at objective data on their sleep patterns and to compare it against brain scans and results from cognitive tests. The team double-checked their results against two additional groups of 13-14 years old, totalling around 1,190 participants. The results are published today in Cell Reports.

The team found that the adolescents could be divided broadly into one of three groups:

Group One, accounting for around 39% of participants, slept an average (mean) of 7 hours 10 mins. They tended to go to bed and fall asleep the latest and wake up the earliest.

Group Two, accounting for 24% of participants, slept an average of 7 hours 21 mins. They had average levels across all sleep characteristics.

Group Three, accounting for 37% of participants, slept an average of 7 hours 25 mins. They tended to go to bed and fall asleep the earliest and had lower heart rates during sleep.

Although the researchers found no significant differences in school achievement between the groups, when it came to cognitive tests looking at aspects such as vocabulary, reading, problem solving and focus, Group Three performed better than Group Two, which in turn performed better than Group One.

Group Three also had the largest brain volume and best brain functions, with Group One the smallest volume and poorest brain functions.

Professor Sahakian said: “Even though the differences in the amount of sleep that each group got was relatively small, at just over a quarter-of-an-hour between the best and worst sleepers, we could still see differences in brain structure and activity and in how well they did at tasks. This drives home to us just how important it is to have a good night’s sleep at this important time in life.”

First author Dr Qing Ma from Fudan University said: “Although our study can’t answer conclusively whether young people have better brain function and perform better at tests because they sleep better, there are a number of studies that would support this idea. For example, research has shown the benefits of sleep on memory, especially on memory consolidation, which is important for learning.”

The researchers also assessed the participants’ heart rates, finding that Group Three had the lowest heart rates across the sleep states and Group One the highest. Lower heart rates are usually a sign of better health, whereas higher rates often accompany poor sleep quality like restless sleep, frequent awakenings and excessive daytime sleepiness.

Because the ABCD Study is a longitudinal study – that is, one that follows its participants over time – the team was able to show that the differences in sleep patterns, brain structure and function, and cognitive performance, tended be present two years before and two years after the snapshot that they looked at.

Senior author Dr Wei Cheng from Fudan University added: “Given the importance of sleep, we now need to look at why some children go to bed later and sleep less than others. Is it because of playing videogames or smartphones, for example, or is it just that their body clocks do not tell them it’s time to sleep until later?”

The research was supported by the National Key R&D Program of China, National Natural Science Foundation of China, National Postdoctoral Foundation of China and Shanghai Postdoctoral Excellence Program. The ABCD Study is supported by the National Institutes of Health.

Reference

Ma, Q et al. Neural correlates of device-based sleep characteristics in adolescents. Cell Reports; 22 Apr 2025; DOI: 10.1016/j.celrep.2025.115565



The text in this work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Images, including our videos, are Copyright ©University of Cambridge and licensors/contributors as identified. All rights reserved. We make our image and video content available in a number of ways – on our main website under its Terms and conditions, and on a range of channels including social media that permit your use and sharing of our content under their respective Terms.

source: cam.ac.uk

Charles Darwin Archive recognised by UNESCO

Two of Charles Darwin’s pocket notebooks. Cambridge University Library
Two of Charles Darwin’s pocket notebooks in Cambridge University Library
Credit: Cambridge University Library

Documentary heritage relating to the life and work of Charles Darwin has been recognised on the prestigious UNESCO International Memory of the World Register, highlighting its critical importance to global science and the necessity of its long-term preservation and accessibility.

We could not be prouder of UNESCO’s recognition of this remarkable documentary heritage
Jessica Gardner

The UNESCO Memory of the World Programme serves as the documentary heritage equivalent of UNESCO World Heritage Sites, protecting invaluable records that tell the story of human civilisation.

A collaboration between Cambridge University Library, the Natural History Museum, the Linnean Society of London, English Heritage’s Down House, the Royal Botanic Gardens, Kew and the National Library of Scotland, the Charles Darwin documentary heritage archive provides a unique window into the life and work of one of the world’s most influential natural scientists.

The complete archive, comprising over 20,000 items across the six major institutions, includes Darwin’s records illustrating the development of his ground-breaking theory of evolution and extensive global travels.

At Cambridge University Library, the Darwin Archive is a significant collection of Darwin’s books, experimental notes, correspondence, and photographs, representing his scientific and personal activities throughout his life.

The collection in Cambridge includes Darwin’s pocket notebooks recording early statements of key ideas contributing to his theory of evolution, notably that species are not stable. These provide important insights into the development of his thought and feature the iconic ‘Tree of Life’ diagram which he drew on his return from the voyage of the HMS Beagle.

The Linnean Society of London holds several of Darwin’s letters, manuscripts and books. Here is also home to John Collier’s original iconic portrait of Charles Darwin, commissioned by the Society and painted in 1883 to commemorate the first reading of the theory of evolution by natural selection at a Linnean Society meeting in 1858.

At the Natural History Museum, a letter written to his wife Emma in 1844, provides insight into Darwin’s perceived significance of his species theory research and holds instructions on what she should do in the case of his sudden death. This is alongside other letters to Museum staff and other family members which demonstrate the broad scope of his scientific thinking, research and communication ranging from caterpillars to volcanoes, dahlias to ants and the taking of photographs for his third publication Expression of the Emotions in Man and Animals.

Correspondence with Darwin’s publisher John Murray, held at the National Library of Scotland document the transformation of his research into print, including the ground-breaking On the Origin of Species publication.

At the Royal Botanic Gardens, Kew, documents include a highly significant collection of 44 letters sent around the HMS Beagle expedition from Darwin to Professor John Stevens Henslow, detailing his travels and the genesis of his theory of evolution as he comes in contact with new plants, wildlife and fossils; as well as a rare sketch of the orchid Gavilea patagonica made by Darwin. Other items include a letter from Darwin to his dear friend Joseph Hooker, Director of Kew in which he requests cotton seeds from Kew’s collections for his research.

Down House (English Heritage) in Kent was both a family home and a place of work where Darwin pursued his scientific interests, carried out experiments, and researched and wrote his many ground-breaking publications until his death in 1882.

The extensive collection amassed by Darwin during his 40 years at Down paint a picture of Darwin’s professional and personal life and the intersection of the two. The archive here includes over 200 books from Darwin’s personal collection, account books, diaries, the Journal of the Voyage of the Beagle MSS, and Beagle notebooks and letters. More personal items include scrapbooks, Emma Darwin’s photograph album and Charles Darwin’s will. The collection at Down House has been mainly assembled through the generous donations of Darwin’s descendants.

This inscription marks a significant milestone in recognising Darwin’s legacy, as it brings together materials held by multiple institutions across the UK for the first time, ensuring that his work’s scientific, cultural, and historical value is preserved for future generations.

In line with the ideals of the UNESCO Memory of the World Programme, much of the Darwin archive can be viewed by the public at the partner institutions and locations.

The UNESCO International Memory of the World Register includes some of the UK’s most treasured documentary heritage, such as the Domesday Book, the Shakespeare Documents, alongside more contemporary materials, including the personal archive of Sir Winston Churchill. The Charles Darwin archive now joins this esteemed list, underscoring its historical, scientific, and cultural significance.

The inscription of the Charles Darwin archive comes as part of UNESCO’s latest recognition of 75 archives worldwide onto the International Memory of the World Register.

These newly inscribed collections include a diverse range of documents, such as the Draft of the International Bill of Human Rights, the papers of Friedrich Nietzche, and the Steles of Shaolin Temple (566-1990) in China.

Baroness Chapman of Darlington, Minister of State for International Development, Latin America and Caribbean, Foreign, Commonwealth & Development Office (FCDO) said: “The recognition of the Charles Darwin archive on UNESCO’s International Memory of the World Register is a proud moment for British science and heritage.

“Darwin’s work fundamentally changed our understanding of the natural world and continues to inspire scientific exploration to this day. By bringing together extraordinary material from our world class British institutions, this archive ensures that Darwin’s groundbreaking work remains accessible to researchers, students, and curious minds across the globe.”

Ruth Padel, FRSL, FZS, poet, conservationist, great-great-grand-daughter of Charles Darwin and King’s College London Professor of Poetry Emerita, said: “How wonderful to see Darwin’s connections to so many outstanding scientific and cultural institutions in the UK reflected in the recognition of his archive on the UNESCO Memory of the World International Register. All these institutions are open to the public so everyone will have access to his documentary heritage.”

Dr Jessica Gardner, University Librarian and Director of Library Services at Cambridge University Libraries (CUL) said: “For all Charles Darwin gave the world, we are delighted by the UNESCO recognition in the Memory of the World of the exceptional scientific and heritage significance of his remarkable archive held within eminent UK institutions.

“Cambridge University Library is home to over 9,000 letters to and from Darwin, as well as his handwritten experimental notebooks, publications, and photographs which have together fostered decades of scholarship and public enjoyment through exhibition, education for schools, and online access.

“We could not be prouder of UNESCO’s recognition of this remarkable documentary heritage at the University of Cambridge, where Darwin was a student at Christ’s College and where his family connections run deep across the city, and are reflected in his namesake, Darwin College.”

Read the full, illustrated version of this story on the University Library’s site.



The text in this work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Images, including our videos, are Copyright ©University of Cambridge and licensors/contributors as identified. All rights reserved. We make our image and video content available in a number of ways – on our main website under its Terms and conditions, and on a range of channels including social media that permit your use and sharing of our content under their respective Terms.

source: cam.ac.uk

Throwing a ‘spanner in the works’ of our cells’ machinery could help fight cancer, fatty liver disease… and hair loss

Bald young man, front view
Bald young man, front view
Credit: bob_bosewell (Getty Images)

Fifty years since its discovery, scientists have finally worked out how a molecular machine found in mitochondria, the ‘powerhouses’ of our cells, allows us to make the fuel we need from sugars, a process vital to all life on Earth.

Drugs inhibiting the function of the carrier can remodel how mitochondria work, which can be beneficial in certain conditionsEdmund Kunji

Scientists at the Medical Research Council (MRC) Mitochondrial Biology Unit, University of Cambridge, have worked out the structure of this machine and shown how it operates like the lock on a canal to transport pyruvate – a molecule generated in the body from the breakdown of sugars – into our mitochondria.

Known as the mitochondrial pyruvate carrier, this molecular machine was first proposed to exist in 1971, but it has taken until now for scientists to visualise its structure at the atomic scale using cryo-electron microscopy, a technique used to magnify an image of an object to around 165,000 times its real size. Details are published today in Science Advances.

Dr Sotiria Tavoulari, a Senior Research Associate from the University of Cambridge, who first determined the composition of this molecular machine, said: “Sugars in our diet provide energy for our bodies to function. When they are broken down inside our cells they produce pyruvate, but to get the most out of this molecule it needs to be transferred inside the cell’s powerhouses, the mitochondria. There, it helps increase 15-fold the energy produced in the form of the cellular fuel ATP.”

Maximilian Sichrovsky, a PhD student at Hughes Hall and joint first author of the study, said: “Getting pyruvate into our mitochondria sounds straightforward, but until now we haven’t been able to understand the mechanism of how this process occurs. Using state-of-the-art cryo-electron microscopy, we’ve been able to show not only what this transporter looks like, but exactly how it works. It’s an extremely important process, and understanding it could lead to new treatments for a range of different conditions.”

Mitochondria are surrounded by two membranes. The outer one is porous, and pyruvate can easily pass through, but the inner membrane is impermeable to pyruvate. To transport pyruvate into the mitochondrion, first an outer ‘gate’ of the carrier opens, allowing pyruvate to enter the carrier. This gate then closes, and the inner gate opens, allowing the molecule to pass through into the mitochondrion.

“It works like the locks on a canal but on the molecular scale,” said Professor Edmund Kunji from the MRC Mitochondrial Biology Unit, and a Fellow at Trinity Hall, Cambridge. “There, a gate opens at one end, allowing the boat to enter. It then closes and the gate at the opposite end opens to allow the boat smooth transit through.”

Because of its central role in controlling the way mitochondria operate to produce energy, this carrier is now recognised as a promising drug target for a range of conditions, including diabetes, fatty liver disease, Parkinson’s disease, specific cancers, and even hair loss.

Pyruvate is not the only energy source available to us. Our cells can also take their energy from fats stored in the body or from amino acids in proteins. Blocking the pyruvate carrier would force the body to look elsewhere for its fuel – creating opportunities to treat a number of diseases. In fatty liver disease, for example, blocking access to pyruvate entry into mitochondria could encourage the body to use potentially dangerous fat that has been stored in liver cells.

Likewise, there are certain tumour cells that rely on pyruvate metabolism, such as in some types of prostate cancer. These cancers tend to be very ‘hungry’, producing excess pyruvate transport carriers to ensure they can feed more. Blocking the carrier could then starve these cancer cells of the energy they need to survive, killing them.

Previous studies have also suggested that inhibiting the mitochondrial pyruvate carrier may reverse hair loss. Activation of human follicle cells, which are responsible for hair growth, relies on metabolism and, in particular, the generation of lactate. When the mitochondrial pyruvate carrier is blocked from entering the mitochondria in these cells, it is instead converted to lactate.

Professor Kunji said: “Drugs inhibiting the function of the carrier can remodel how mitochondria work, which can be beneficial in certain conditions. Electron microscopy allows us to visualise exactly how these drugs bind inside the carrier to jam it – a spanner in the works, you could say. This creates new opportunities for structure-based drug design in order to develop better, more targeted drugs. This will be a real game changer.”

The research was supported by the Medical Research Council and was a collaboration with the groups of Professors Vanessa Leone at the Medical College of Wisconsin, Lucy Forrest at the National Institutes of Health, and Jan Steyaert at the Free University of Brussels.

Reference

Sichrovsky, M, Lacabanne, D, Ruprecht, JJ & Rana, JJ et al. Molecular basis of pyruvate transport and inhibition of the human mitochondrial pyruvate carrier. Sci Adv; 18 Apr 2025; DOI: 10.1126/sciadv.adw1489



The text in this work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Images, including our videos, are Copyright ©University of Cambridge and licensors/contributors as identified. All rights reserved. We make our image and video content available in a number of ways – on our main website under its Terms and conditions, and on a range of channels including social media that permit your use and sharing of our content under their respective Terms.

source: cam.ac.uk

Extreme drought contributed to barbarian invasion of late Roman Britain, tree-ring study reveals

Milecastle 39 on Hadrian's Wall
Milecastle 39 on Hadrian’s Wall
Credit: Adam Cuerden

Three consecutive years of drought contributed to the ‘Barbarian Conspiracy’, a pivotal moment in the history of Roman Britain, a new Cambridge-led study reveals. Researchers argue that Picts, Scotti and Saxons took advantage of famine and societal breakdown caused by an extreme period of drought to inflict crushing blows on weakened Roman defences in 367 CE. While Rome eventually restored order, some historians argue that the province never fully recovered.

Our findings provide an explanation for the catalyst of this major event.
Charles Norman

The ‘Barbarian Conspiracy’ of 367 CE was one of the most severe threats to Rome’s hold on Britain since the Boudiccan revolt three centuries earlier. Contemporary sources indicate that components of the garrison on Hadrian’s wall rebelled and allowed the Picts to attack the Roman province by land and sea. Simultaneously, the Scotti from modern-day Ireland invaded broadly in the west, and Saxons from the continent landed in the south.

Senior Roman commanders were captured or killed, and some soldiers reportedly deserted and joined the invaders. Throughout the spring and summer, small groups roamed and plundered the countryside. Britain’s descent into anarchy was disastrous for Rome and it took two years for generals dispatched by Valentian I, Emperor of the Western Roman Empire, to restore order. The final remnants of official Roman administration left Britain some 40 years later around 410 CE.

The University of Cambridge-led study, published today in Climatic Change, used oak tree-ring records to reconstruct temperature and precipitation levels in southern Britain during and after the ‘Barbarian Conspiracy’ in 367 CE. Combining this data with surviving Roman accounts, the researchers argue that severe summer droughts in 364, 365 and 366 CE were a driving force in these pivotal events.

First author Charles Norman, from Cambridge’s Department of Geography, said: “We don’t have much archaeological evidence for the ‘Barbarian Conspiracy’. Written accounts from the period give some background, but our findings provide an explanation for the catalyst of this major event.”

The researchers found that southern Britain experienced an exceptional sequence of remarkably dry summers from 364 to 366 CE. In the period 350 to 500 CE, average monthly reconstructed rainfall in the main growing season (April–July) was 51 mm. But in 364 CE, it fell to just 29mm. 365 CE was even worse with 28mm, and 37mm the following year kept the area in crisis.

Professor Ulf Büntgen, from Cambridge’s Department of Geography, said: “Three consecutive droughts would have had a devastating impact on the productivity of Roman Britain’s most important agricultural region. As Roman writers tell us, this resulted in food shortages with all of the destabilising societal effects this brings.”

Between 1836 and 2024 CE, southern Britain only experienced droughts of a similar magnitude seven times – mostly in recent decades, and none of these were consecutive, emphasising how exceptional these droughts were in Roman times. The researchers identified no other major droughts in southern Britain in the period 350–500 CE and found that other parts of northwestern Europe escaped these conditions.

Roman Britain’s main produce were crops like spelt wheat and six-row barley. Because the province had a wet climate, sowing these crops in spring was more viable than in winter, but this made them vulnerable to late spring and early summer moisture deficits, and early summer droughts could lead to total crop failure.

The researchers point to surviving accounts written by Roman chroniclers to corroborate these drought-driven grain deficits. By 367 CE, Ammianus Marcellinus described the population of Britain as in the ‘utmost conditions of famine’.

“Drought from 364 to 366 CE would have impacted spring-sown crop growth substantially, triggering poor harvests,” Charles Norman said. “This would have reduced the grain supply to Hadrian’s Wall, providing a plausible motive for the rebellion there which allowed the Picts into northern Britain.”

The study suggests that given the crucial role of grain in the contract between soldiers and the army, grain deficits may have contributed to other desertions in this period, and therefore a general weakening of the Roman army in Britain. In addition, the geographic isolation of Roman Britain likely combined with the severity of the prolonged drought to reduce the ability of Rome to alleviate the deficits.

Ultimately the researchers argue that military and societal breakdown in Roman Britain provided an ideal opportunity for peripheral tribes, including the Picts, Scotti and Saxons, to invade the province en masse with the intention of raiding rather than conquest. Their finding that the most severe conditions were restricted to southern Britain undermines the idea that famines in other provinces might have forced these tribes to invade.

Andreas Rzepecki, from the Generaldirektion Kulturelles Erbe Rheinland-Pfalz, said: “Our findings align with the accounts of Roman chroniclers and the seemingly coordinated nature of the ‘Conspiracy’ suggests an organised movement of strong onto weak, rather than a more chaotic assault had the invaders been in a state of desperation.”

“The prolonged and extreme drought seems to have occurred during a particularly poor period for Roman Britain, in which food and military resources were being stripped for the Rhine frontier, while immigratory pressures increased.”

“These factors limited resilience, and meant a drought induced, partial-military rebellion and subsequent external invasion were able to overwhelm the weakened defences.”

The researchers expanded their climate-conflict analysis to the entire Roman Empire for the period 350–476 CE. They reconstructed the climate conditions immediately before and after 106 battles and found that a statistically significant number of battles were fought following dry years.

Tatiana Bebchuk, from Cambridge’s Department of Geography, said: “The relationship between climate and conflict is becoming increasingly clear in our own time so these findings aren’t just important for historians. Extreme climate conditions lead to hunger, which can lead to societal challenges, which eventually lead to outright conflict.”

Charles Norman, Ulf Büntgen, Paul Krusic and Tatiana Bebchuk are based at the Department of Geography, University of Cambridge; Lothar Schwinden and Andreas Rzepecki are from the Generaldirektion Kulturelles Erbe Rheinland-Pfalz in Trier. Ulf Büntgen is also affiliated with the Global Change Research Institute, Czech Academy of Sciences and the Department of Geography, Masaryk University in Brno.

Reference

C Norman, L Schwinden, P Krusic, A Rzepecki, T Bebchuk, U Büntgen, ‘Droughts and conflicts during the late Roman period’, Climatic Change (2025). DOI: 10.1007/s10584-025-03925-4

Funding

Charles Norman was supported by Wolfson College, University of Cambridge (John Hughes PhD Studentship). Ulf Büntgen received funding from the Czech Science Foundation (# 23-08049S; Hydro8), the ERC Advanced Grant (# 882727; Monostar), and the ERC Synergy Grant (# 101118880; Synergy-Plague).



The text in this work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Images, including our videos, are Copyright ©University of Cambridge and licensors/contributors as identified. All rights reserved. We make our image and video content available in a number of ways – on our main website under its Terms and conditions, and on a range of channels including social media that permit your use and sharing of our content under their respective Terms.

source: cam.ac.uk

Mouse study suggests a common diabetes drug may prevent leukaemia

Brown lab mouse on blue gloved hand
Brown lab mouse on blue gloved hand
Credit: University of Cambridge

Metformin, a widely used and affordable diabetes drug, could prevent a form of acute myeloid leukaemia in people at high risk of the disease, a study in mice has suggested. Further research in clinical trials will be needed to confirm this works for patients.

We’ve done the extensive research all the way from cell-based studies to human data, so we’re now at the point where we have a made a strong case for moving ahead with clinical trials
Brian Huntly

Around 3,100 people are diagnosed with acute myeloid leukaemia (AML) each year in the UK. It is an aggressive form of blood cancer that is very difficult to treat. Thanks to recent advances, individuals at high risk of AML can be identified years in advance using blood tests and blood DNA analysis, but there’s no suitable treatment that can prevent them from developing the disease.

In this study, Professor George Vassiliou and colleagues at the University of Cambridge investigated how to prevent abnormal blood stem cells with genetic changes from progressing to become AML. The work focused on the most common genetic change, which affects a gene called DNMT3A and is responsible for starting 10-15% of AML cases.

Professor Vassiliou, from the Cambridge Stem Cell Institute at the University of Cambridge and Honorary Consultant Haematologist at Cambridge University Hospitals NHS Foundation Trust (CUH) co-led the study. He said: “Blood cancer poses unique challenges compared to solid cancers like breast or prostate, which can be surgically removed if identified early. With blood cancers, we need to identify people at risk and then use medical treatments to stop cancer progression throughout the body.”

The research team examined blood stem cells from mice with the same changes in DNMT3A as seen in the pre-cancerous cells in humans. Using a genome-wide screening technique, they showed that these cells depend more on mitochondrial metabolism than healthy cells, making this a potential weak spot. The researchers went on to confirm that metformin, and other mitochondria-targeting drugs, substantially slowed the growth of mutation-bearing blood cells in mice. Further experiments also showed that metformin could have the same effect on human blood cells with the DNMT3A mutation.

Dr Malgorzata Gozdecka, Senior Research Associate at the Cambridge Stem Cell Institute and first author of the research said: “Metformin is a drug that impacts mitochondrial metabolism, and these pre-cancerous cells need this energy to keep growing. By blocking this process, we stop the cells from expanding and progressing towards AML, whilst also reversing other effects of the mutated DNMT3A gene.”

In addition, the study looked at data from over 412,000 UK Biobank volunteers and found that people taking metformin were less likely to have changes in the DNMT3A gene. This link remained even after accounting for factors that could have confounded the results such as diabetes status and BMI.

Professor Brian Huntly, Head of the Department of Haematology at the University of Cambridge, Honorary Consultant Haematologist at CUH, and joint lead author of the research, added: “Metformin appears highly specific to this mutation rather than being a generic treatment. That specificity makes it especially compelling as a targeted prevention strategy.

“We’ve done the extensive research all the way from cell-based studies to human data, so we’re now at the point where we have a made a strong case for moving ahead with clinical trials. Importantly, metformin’s lack of toxicity will be a major advantage as it is already used by millions of people worldwide with a well-established safety profile.”

The results of the study, funded by Blood Cancer UK with additional support from Cancer Research UK, the Leukemia & Lymphoma Society (USA) and the Wellcome Trust, are published in Nature.

Dr Rubina Ahmed, Director of Research at Blood Cancer UK, said: “Blood cancer is the third biggest cancer killer in the UK, with over 280,000 people currently living with the disease. Our Blood Cancer Action plan shed light on the shockingly low survival for acute myeloid leukaemia, with only around 2 in 10 surviving for 5 years, and we urgently need better strategies to save lives. Repurposing safe, widely available drugs like metformin means we could potentially get new treatments to people faster, without the need for lengthy drug development pipelines.”

The next phase of this research will focus on clinical trials to test metformin’s effectiveness in people with changes in DNMT3A at increased risk of developing AML.  With metformin already approved and widely used for diabetes, this repurposing strategy could dramatically reduce the time it takes to bring a new preventive therapy to patients.

Tanya Hollands, Research Information Manager at Cancer Research UK, who contributed funding for the lab-based screening in mice, said: “It’s important that we work to find new ways to slow down or prevent AML in people at high risk. Therefore, it’s positive that the findings of this study suggest a possible link between a commonly-used diabetes drug and prevention of AML progression in some people. While this early-stage research is promising, clinical trials are now needed to find out if this drug could benefit people. We look forward to seeing how this work progresses.”

Reference
Gozdecka, M et al. Mitochondrial metabolism sustains DNMT3A-R882-mutant clonal haematopoiesis. Nature; 16 Apr 2025; DOI: 10.1038/s41586-025-08980-6

Adapted from a press release from Blood Cancer UK



The text in this work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Images, including our videos, are Copyright ©University of Cambridge and licensors/contributors as identified. All rights reserved. We make our image and video content available in a number of ways – on our main website under its Terms and conditions, and on a range of channels including social media that permit your use and sharing of our content under their respective Terms.

source: cam.ac.uk

Growing wildflowers on disused urban land can damage bee health

Chicory growing on unused land in Cleveland, USA.
Chicory growing in a vacant lot
Credit: Sarah Scott

Wildflowers growing on land previously used for buildings and factories can accumulate lead, arsenic and other metal contaminants from the soil, which are consumed by pollinators as they feed, a new study has found.

Our results should not discourage people from planting wildflowers in towns and cities. But.. it’s important to consider the history of the land and what might be in the soil.”Sarah Scott

The metals have previously been shown to damage the health of pollinators, which ingest them in nectar as they feed, leading to reduced population sizes and death. Even low nectar metal levels can have long-term effects, by affecting bees’ learning and memory – which impacts their foraging ability.

Researchers have found that common plants including white clover and bindweed, which are vital forage for pollinators in cities, can accumulate arsenic, cadmium, chromium and lead from contaminated soils.

Metal contamination is an issue in the soils of cities worldwide, with the level of contamination usually increasing with the age of a city. The metals come from a huge range of sources including cement dust and mining.

The researchers say soils in cities should be tested for metals before sowing wildflowers and if necessary, polluted areas should be cleaned up before new wildflower habitats are established.

The study highlights the importance of growing the right species of wildflowers to suit the soil conditions.

Reducing the risk of metal exposure is critical for the success of urban pollinator conservation schemes. The researchers say it is important to manage wildflower species that self-seed on contaminated urban land, for example by frequent mowing to limit flowering – which reduces the transfer of metals from the soil to the bees.

The results are published today in the journal Ecology and Evolution.

Dr Sarah Scott in the University of Cambridge’s Department of Zoology and first author of the report, said: “It’s really important to have wildflowers as a food source for the bees, and our results should not discourage people from planting wildflowers in towns and cities.

“We hope this study will raise awareness that soil health is also important for bee health. Before planting wildflowers in urban areas to attract bees and other pollinators, it’s important to consider the history of the land and what might be in the soil – and if necessary find out whether there’s a local soil testing and cleanup service available first.”

The study was carried out in the post-industrial US city of Cleveland, Ohio, which has over 33,700 vacant lots left as people have moved away from the area. In the past, iron and steel production, oil refining and car manufacturing went on there. But any land that was previously the site of human activity may be contaminated with traces of metals.

To get their results, the researchers extracted nectar from a range of self-seeded flowering plants that commonly attract pollinating insects, found growing on disused land across the city. They tested this for the presence of arsenic, cadmium, chromium and lead. Lead was consistently found at the highest concentrations, reflecting the state of the soils in the city.

The researchers found that different species of plant accumulate different amounts, and types, of the metals. Overall, the bright blue-flowered chicory plant (Cichorium intybus) accumulated the largest total metal concentration, followed by white clover (Trifolium repens), wild carrot (Daucus carota) and bindweed (Convolvulus arvensis). These plants are all vital forage for pollinators in cities – including cities in the UK – providing a consistent supply of nectar across locations and seasons.

There is growing evidence that wild pollinator populations have dropped by over 50% in the last 50 years, caused primarily by changes in land use and management across the globe. Climate change and pesticide use also play a role; overall the primary cause of decline is the loss of flower-rich habitat.

Pollinators play a vital role in food production: many plants, including apple and tomato, require pollination in order to develop fruit. Natural ‘pollination services’ are estimated to add billions of dollars to global crop productivity.

Scott said: “Climate change feels so overwhelming, but simply planting flowers in certain areas can help towards conserving pollinators, which is a realistic way for people to make a positive impact on the environment.”

The research was funded primarily by the USDA National Institute of Food and Agriculture.

Reference
Scott, SB and Gardiner, MM: ‘Trace metals in nectar of important urban pollinator forage plants: A direct exposure risk to pollinators and nectar-feeding animals in cities.’ Ecology and Evolution, April 2025. DOI: 10.1002/ece3.71238



The text in this work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Images, including our videos, are Copyright ©University of Cambridge and licensors/contributors as identified. All rights reserved. We make our image and video content available in a number of ways – on our main website under its Terms and conditions, and on a range of channels including social media that permit your use and sharing of our content under their respective Terms.

source: cam.ac.uk

Complete clean sweep for Cambridge at The Boat Race 2025

Credit: Row360

Cambridge is celebrating a complete clean sweep at The Boat Race 2025, with victories in all 4 openweight races and also both lightweight races.

Thousands of spectators lined the banks of the River Thames on 13 April to witness a dramatic afternoon of action, with millions more following live on the BBC.

Cambridge Women secured their eighth consecutive win in the 79th Women’s Boat Race, extending their overall record to 49 victories to Oxford’s 30. The Men’s crew, too, were victorious in defending their title in the 170th edition of the event, notching up their 88th win, with Oxford sitting on 81.

Goldie, the Cambridge Men’s Reserve Crew, won the Men’s Reserve Race, while Blondie, the Cambridge Women’s Reserve Crew, won the Women’s Reserve Race. And the day before, the 2025 Lightweight Boat Race also saw two wins for Cambridge.

Cambridge’s Claire Collins said it was an incredible feeling to win the race. 

“This is so cool, it’s really an incredible honour to share this with the whole club,” she said.

The Women’s Race was stopped initially after an oar clash, but Umpire Sir Matthew Pinsent allowed the race to resume after a restart. Claire said that the crew had prepared for eventualities such as a restart and so were able to lean on their training when it happened.

“I had total confidence in the crew to regroup. Our focus was to get back on pace and get going as soon as possible and that’s what we did.”

For Cambridge Men’s President Luca Ferraro, it was his final Boat Roat campaign, having raced in the Blue Boat for the last three years, winning the last two.

He said: “It was a great race. The guys really stepped up. That’s something that our Coach Rob Baker said to us before we went out there, that each of us had to step up individually and come together and play our part in what we were about to do. I couldn’t be prouder of the guys, they really delivered today.”

Professor Deborah Prentice, Vice-Chancellor of the University of Cambridge, congratulated all the crews following the wins.

“I am in awe of these students and what they have achieved, and what Cambridge University Boat Club has been able to create,” she said.

“These students are out in the early hours of the morning training and then trying to make it to 9am lectures. It’s so inspiring. And a complete clean sweep – this was an incredibly impressive showing by Cambridge, I am so proud of them.”

The Cambridge Blue Boats featured student athletes drawn from Christ’s College, Downing College, Emmanuel College, Gonville & Caius, Hughes Hall, Jesus College, Pembroke College, Peterhouse, St Edmund’s, and St John’s.



The text in this work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Images, including our videos, are Copyright ©University of Cambridge and licensors/contributors as identified. All rights reserved. We make our image and video content available in a number of ways – on our main website under its Terms and conditions, and on a range of channels including social media that permit your use and sharing of our content under their respective Terms.

source: cam.ac.uk

Harmful effects of digital tech – the science ‘needs fixing’, experts argue

Illustration representing potential online harms
Illustration representing potential online harms
Credit: Nuthawut Somsuk via Getty

From social media to AI, online technologies are changing too fast for the scientific infrastructure used to gauge its public health harms, say two leaders in the field.

The scientific methods and resources we have for evidence creation at the moment simply cannot deal with the pace of digital technology developmentDr Amy Orben

Scientific research on the harms of digital technology is stuck in a “failing cycle” that moves too slowly to allow governments and society to hold tech companies to account, according to two leading researchers in a new report published in the journal Science.

Dr Amy Orben from the University of Cambridge and Dr J. Nathan Matias from Cornell University say the pace at which new technology is deployed to billions of people has put unbearable strain on the scientific systems trying to evaluate its effects.

They argue that big tech companies effectively outsource research on the safety of their products to independent scientists at universities and charities who work with a fraction of the resources – while firms also obstruct access to essential data and information. This is in contrast to other industries where safety testing is largely done “in house”.

Orben and Matias call for an overhaul of “evidence production” assessing the impact of technology on everything from mental health to discrimination.  

Their recommendations include accelerating the research process, so that policy interventions and safer designs are tested in parallel with initial evidence gathering, and creating registries of tech-related harms informed by the public.    

“Big technology companies increasingly act with perceived impunity, while trust in their regard for public safety is fading,” said Orben, of Cambridge’s MRC Cognition and Brain Sciences Unit. “Policymakers and the public are turning to independent scientists as arbiters of technology safety.”

“Scientists like ourselves are committed to the public good, but we are asked to hold to account a billion-dollar industry without appropriate support for our research or the basic tools to produce good quality evidence quickly.”

“We must urgently fix this science and policy ecosystem so we can better understand and manage the potential risks posed by our evolving digital society,” said Orben.

‘Negative feedback cycle’

In the latest Science paper, the researchers point out that technology companies often follow policies of rapidly deploying products first and then looking to “debug” potential harms afterwards. This includes distributing generative AI products to millions before completing basic safety tests, for example.

When tasked with understanding potential harms of new technologies, researchers rely on “routine science” which – having driven societal progress for decades – now lags the rate of technological change to the extent that it is becoming at times “unusable”.  

With many citizens pressuring politicians to act on digital safety, Orben and Matias argue that technology companies use the slow pace of science and lack of hard evidence to resist policy interventions and “minimize their own responsibility”.

Even if research gets appropriately resourced, they note that researchers will be faced with understanding products that evolve at an unprecedented rate.

“Technology products change on a daily or weekly basis, and adapt to individuals. Even company staff may not fully understand the product at any one time, and scientific research can be out of date by the time it is completed, let alone published,” said Matias, who leads Cornell’s Citizens and Technology (CAT) Lab.

“At the same time, claims about the inadequacy of science can become a source of delay in technology safety when science plays the role of gatekeeper to policy interventions,” Matias said.

“Just as oil and chemical industries have leveraged the slow pace of science to deflect the evidence that informs responsibility, executives in technology companies have followed a similar pattern. Some have even allegedly refused to commit substantial resources to safety research without certain kinds of causal evidence, which they also decline to fund.” 

The researchers lay out the current “negative feedback cycle”:

Tech companies do not adequately resource safety research, shifting the burden to independent scientists who lack data and funding. This means high-quality causal evidence is not produced in required timeframes, which weakens government’s ability to regulate – further disincentivising safety research, as companies are let off the hook.

Orben and Matias argue that this cycle must be redesigned, and offer ways to do it.

Reporting digital harms

To speed up the identification of harms caused by online technologies, policymakers or civil society could construct registries for incident reporting, and encourage the public to contribute evidence when they experience harms.

Similar methods are already used in fields such as environmental toxicology where the public reports on polluted waterways, or vehicle crash reporting programs that inform automotive safety, for example.

“We gain nothing when people are told to mistrust their lived experience due to an absence of evidence when that evidence is not being compiled,” said Matias.

Existing registries, from mortality records to domestic violence databases, could also be augmented to include information on the involvement of digital technologies such as AI.

The paper’s authors also outline a “minimum viable evidence” system, in which policymakers and researchers adjust the “evidence threshold” required to show potential technological harms before starting to test interventions.

These evidence thresholds could be set by panels made up of affected communities, the public, or “science courts”: expert groups assembled to make rapid assessments.   

“Causal evidence of technological harms is often required before designers and scientists are allowed to test interventions to build a safer digital society,” said Orben. 

“Yet intervention testing can be used to scope ways to help individuals and society, and pinpoint potential harms in the process. We need to move from a sequential system to an agile, parallelised one.”

Under a minimum viable evidence system, if a company obstructs or fails to support independent research, and is not transparent about their own internal safety testing, the amount of evidence needed to start testing potential interventions would be decreased.

Orben and Matias also suggest learning from the success of “Green Chemistry”, which sees an independent body hold lists of chemical products ranked by potential for harm, to help incentivise markets to develop safer alternatives.

“The scientific methods and resources we have for evidence creation at the moment simply cannot deal with the pace of digital technology development,” Orben said.  

“Scientists and policymakers must acknowledge the failures of this system and help craft a better one before the age of AI further exposes society to the risks of unchecked technological change.”

Added Matias: “When science about the impacts of new technologies is too slow, everyone loses.”



The text in this work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Images, including our videos, are Copyright ©University of Cambridge and licensors/contributors as identified. All rights reserved. We make our image and video content available in a number of ways – on our main website under its Terms and conditions, and on a range of channels including social media that permit your use and sharing of our content under their respective Terms.

source: cam.ac.uk

Cambridge research: First global bond index to address fossil fuel expansion

University of Cambridge researchers based at the Department for Land Economy have selected index provider Bloomberg Index Services Limited to launch the first global corporate bond index to cover fossil fuel producers, utilities, insurance, and financing, with the aim of driving investment to reduce real-economy emissions.

This is an enormously impactful project which showcases the high-quality research undertaken at CambridgeAnthony Odgers, University of Cambridge Chief Financial Officer

This is a critical – and hugely challenging – moment for climate action. Legal and political pressures have paralysed asset managers and other financial service providers, leading to a recent wave of actors leaving investor climate coalitions. However, asset owners are increasingly seeing the need to take a leadership role in addressing climate change, which threatens the long-term future of their portfolios and the wider economy.

That’s why we are delighted to announce that Cambridge researchers based at the Department for Land Economy have selected index provider Bloomberg Index Services Limited to launch the first global corporate bond index to cover fossil fuel producers, utilities, insurance, and financing, with the aim of driving investment to reduce real-economy emissions.

You can read the University press release here.

“We are delighted that this project has reached such a key milestone,” said Professor Martin Dixon, Head of the Department of Land Economy. “As a multidisciplinary department with a focus on outstanding academic publication and teaching, this project has the potential to serve as a ‘systems demonstrator’ for ongoing research in this important area.”

Why a bond index?

The launch of the bond index by an 816-year-old institution is an unusual process and a tale worth telling. It began with a peer-reviewed paper by Dr Ellen Quigley, Principal Research Associate at Land Economy, exploring the case for evidence-based climate impact by institutional investors. This was followed by an internal feasibility study based at Jesus College, Cambridge (which continues to co-host the project), and supported by several other parts of the University.

With feasibility assessed, the team went out to global index providers to explore their interest. All of the leading players were interested in building this index, yet all grappled with a lack of access to data and the complexity of assessing companies based on their activities (e.g., whether they were building new fossil fuel infrastructure), not their business classification. An extensive Request for Proposals process resulted in naming Bloomberg Index Services Limited as our provider. The project aims to provide a genuine solution for asset owners looking to align their corporate debt instruments with their climate targets and to avoid both ineffective blanket interventions and greenwashing.

The central problem, on which the industry has faltered for decades, is how to manage the risk presented by a fossil fuel industry that continues to grow. Leading climate scenarios such as the International Energy Agency’s Net Zero by 2050 scenario are clear that fossil fuel expansion is inconsistent with the transition to a decarbonised economy.  With approximately 90% of new financing for fossil fuel expansion coming from bonds and bank loans, debt markets must be the focus of investor efforts to transition away from fossil fuel expansionism. Bonds offer a larger pool of capital than equities, and a greater proportion are purchased in the primary market, where companies gain access to new capital.

The past decade has seen a significant rise in passive investment strategies and therefore an increase in financial flows into index funds, which have as a consequence become significant ‘auto-allocators’ of capital. This research project aims to study the extent to which the new bond index influences cost, volume, and access to capital among companies who are seeking to build new fossil fuel infrastructure and delaying the phase-down of their operations. Bond markets are not just a key part of investor action on climate change: they are the very coalface of fossil fuel expansion, i.e. new gas, oil, and coal extraction and infrastructure.

“This is an enormously impactful project which showcases the high-quality research undertaken at Cambridge,” University of Cambridge Chief Financial Officer Anthony Odgers said.  “The index is a game-changer for the growing number of asset owners who invest in corporate debt and understand its impact on fossil fuel expansion, particularly the construction of new fossil fuel infrastructure such as coal- and gas-fired power plants which risk locking in fossil fuel usage for decades.”

“Once the index launches, Cambridge expects to invest some of its own money against financial products referencing it. This will enable us to align our fixed income holdings with our institution-wide objectives,” Odgers said.

There are currently no off-the-shelf products that allow for passive investments in global corporate bond markets without financing fossil fuel expansion, through fossil fuel production, utilities building new coal- and gas-fired power plants, and through the banks and insurers that continue to finance and underwrite these activities. By supporting the development of this ‘systems demonstrator’, we will be able to conduct essential research on the efficacy of such a lever.

“Instead of linear year-on-year reductions or blanket bans by business classification, the index methodology identifies companies that present the greatest systemic risks to investors, while ensuring that those companies that meet the criteria can rejoin the bond index,” said project leader Lily Tomson, a Senior Research Associate at Jesus College, Cambridge. 

Several years of close collaboration with leading global asset owners such as California State Teachers Retirement System (CalSTRS), Universities Superannuation Scheme (USS), Swiss Federal Pension Fund PUBLICA and the United Nations Joint Staff Pension Fund (UNJSPF) provided input and technical market expertise that underpins the index. Alongside the University of Cambridge, the index will be used at launch by investments from the United Nations Joint Staff Pension Fund.

“Finally, large asset owners around the world have an index for this market that aims to discourage the expansion of fossil fuels,” said Pedro Guazo, Representative of the Secretary-General (RSG) for the investment of the UNJSPF assets.

Rules-based engagement: a lever for behaviour change

Debt benchmarks have a key role to play in any real efforts to tackle the expansion of fossil fuels. This project is innovative because it focuses on exclusions and weightings of companies based on their current corporate activity, instead of using an approach that relies on blanket exclusions by business classification (which does not generate incentives to change behaviour). For example, a company might be classed as a fossil fuel company, but if it stops expanding new fossil fuel operations and aligns to an appropriate phase-down pathway, the company has an opportunity to be included in the index and gain access to capital via funds which use the index, as a result.

Across the project, we are using data sources that have never previously been used to build an index – for example, the Global Coal Exit List (GCEL) and Global Oil and Gas Exit List (GOGEL) from Urgewald. We are taking a novel approach that focuses investor attention on those actors that our framework considers ‘edge cases’: companies close to reaching, or moving away from, alignment with the index. Companies have the option of being (re-)included in the index if they change their behaviour to align with the rules of the index. Academic literature suggests this is a lever for behaviour change in equities, but as an approach it is new to debt market indices. This is one of many key hypotheses that this project tests. We are convening a community of leading global academics who will support the creation of this new form of rules-based bondholder engagement.

This bond index project is one of a suite of actions rooted in academic research and collaboration that have been developed by the collegiate University. Alongside 74 other higher education institutions, Cambridge is delivering a parallel project focused on cash deposits and money market funds. We will continue to conduct research as the associated new products begin to operate through 2025.

At a time when climate damage is growing rapidly and is visible in news stories around the world, many actors across investment markets are looking for a clear path to take necessary action. As an academic institution and a long-term investor, the University of Cambridge is committed to supporting evidence-based research and action on climate change.

The bond index will be launched later this year. If you are interested in finding out more about the project or the team’s research, contact us here: bondindex@landecon.cam.ac.uk.



The text in this work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Images, including our videos, are Copyright ©University of Cambridge and licensors/contributors as identified. All rights reserved. We make our image and video content available in a number of ways – on our main website under its Terms and conditions, and on a range of channels including social media that permit your use and sharing of our content under their respective Terms.

source: cam.ac.uk

Scientists create ‘metal detector’ to hunt down tumours

Serena Nik-Zainal at the Early Cancer Institute
Serena Nik-Zainal at the Early Cancer Institute
Credit: University of Cambridge

Cambridge researchers have created a ‘metal detector’ algorithm that can hunt down vulnerable tumours, in a development that could one day revolutionise the treatment of cancer.

Genomic sequencing is now far faster and cheaper than ever before. We are getting closer to the point where getting your tumour sequenced will be as routine as a scan or blood testSerena Nik-Zainal

In a paper published today in Nature Genetics, scientists at the University of Cambridge and NIHR Cambridge Biomedical Research Centre analysed the full DNA sequence of 4,775 tumours from seven types of cancer. They used that data from Genomics England’s 100,000 Genomes Project to create an algorithm capable of identifying tumours with faults in their DNA that makes them easier to treat.

The algorithm, called PRRDetect, could one day help doctors work out which patients are more likely to have successful treatment. That could pave the way for more personalised treatment plans that increase people’s chances of survival.

The research was funded by Cancer Research UK and the National Institute for Health and Care Research (NIHR).

Professor Serena Nik-Zainal  from the Early Cancer Institute at the University of Cambridge, lead author of the study, said: “Genomic sequencing is now far faster and cheaper than ever before. We are getting closer to the point where getting your tumour sequenced will be as routine as a scan or blood test.

“To use genomics most effectively in the clinic, we need tools which give us meaningful information about how a person’s tumour might respond to treatment. This is especially important in cancers where survival is poorer, like lung cancer and brain tumours.

“Cancers with faulty DNA repair are more likely to be treated successfully. PRRDetect helps us better identify those cancers and, as we sequence more and more cancers routinely in the clinic, it could ultimately help doctors better tailor treatments to individual patients.”

The research team looked for patterns in DNA created by so-called ‘indel’ mutations, in which letters are inserted or deleted from the normal DNA sequence.  

They found unusual patterns of indel mutations in cancers that had faulty DNA repair mechanisms – known as ‘post-replicative repair dysfunction’ or PRRd. Using this information, the scientists developed PRRDetect to allow them to identify tumours with this fault from a full DNA sequence.

PRRd tumours are more sensitive to immunotherapy, a type of cancer treatment that uses the body’s own immune system to attack cancer cells. The scientists hope that the PRRd algorithm could act like a ‘metal detector’ to allow them to identify patients who are more likely to have successful treatment with immunotherapy.

The study follows from a previous ‘archaeological dig’ of cancer genomes carried out by Professor Nik-Zainal, which examined the genomes of tens of thousands of people and revealed previously unseen patterns of mutations which are linked to cancer.

This time, Professor Nik-Zainal and her team looked at cancers which have a higher proportion of tumours with PRRd. These include bowel, brain, endometrial, skin, lung, bladder and stomach cancers. Whole genome sequences of these cancers were provided by the 100,000 Genomes Project – a pioneering study led by Genomics England and NHS England which sequenced 100,000 genomes from around 85,000 NHS patients affected by rare diseases or cancer.

The study identified 37 different patterns of indel mutations across the seven cancer types included in this study. Ten of these patterns were already linked to known causes of cancer, such as smoking and exposure to UV light. Eight of these patterns were linked to PRRd. The remaining 19 patterns were new and could be linked to causes of cancer that are not fully understood yet or mechanisms within cells that can go wrong when a cell becomes cancerous.

Executive Director of Research and Innovation at Cancer Research UK, Dr Iain Foulkes, said: “Genomic medicine will revolutionise how we approach cancer treatment. We can now get full readouts of tumour DNA much more easily, and with that comes a wealth of information about how an individual’s cancer can start, grow and spread.

“Tools like PRRDetect are going to make personalised treatment for cancer a reality for many more patients in the future. Personalising treatment is much more likely to be successful, ensuring more people can live longer, better lives free from the fear of cancer.”

NIHR Scientific Director, Mike Lewis, said: “Cancer is a leading cause of death in the UK so it’s impressive to see our research lead to the creation of a tool to determine which therapy will lead to a higher likelihood of successful cancer treatment.”

Chief Scientific Officer at Genomics England, Professor Matt Brown, said: “Genomics is playing an increasingly important role in healthcare and these findings show how genomic data can be used to drive more predictive, preventative care leading to better outcomes for patients with cancer.

“The creation of this algorithm showcases the immense value of whole genome sequencing not only in research but also in the clinic across multiple diverse cancer types in advancing cancer care.”

The University of Cambridge is fundraising for a new hospital that will transform how we diagnose and treat cancer. Cambridge Cancer Research Hospital, a partnership with Cambridge University Hospitals NHS Foundation Trust, will treat patients across the East of England, but the research that takes place there promises to change the lives of cancer patients across the UK and beyond. Find out more here.

Reference

Koh, GCC et al. Redefined indel taxonomy reveals insights into mutational signatures. Nat Gen; 10 Apr 2025; DOI:

Adapted from a press release from Cancer Research UK



The text in this work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Images, including our videos, are Copyright ©University of Cambridge and licensors/contributors as identified. All rights reserved. We make our image and video content available in a number of ways – on our main website under its Terms and conditions, and on a range of channels including social media that permit your use and sharing of our content under their respective Terms.

source: cam.ac.uk

Handheld device could transform heart disease screening

Person wearing a grey t-shirt holding a palm-sized device to their chest
Person demonstrating use of a handheld device for heart disease screening
Credit: Acoustics Lab

Researchers have developed a handheld device that could potentially replace stethoscopes as a tool for detecting certain types of heart disease.

This device could become an affordable and scalable solution for heart health screening, especially in areas with limited medical resourcesAnurag Agarwal

The researchers, from the University of Cambridge, developed a device that makes it easy for people with or without medical training to record heart sounds accurately. Unlike a stethoscope, the device works well even if it’s not placed precisely on the chest: its larger, flexible sensing area helps capture clearer heart sounds than traditional stethoscopes.

The device can also be used over clothing, making it more comfortable for patients – especially women – during routine check-ups or community heart health screening programmes.

The heart sound recordings can be saved on the device, which can then be used to detect signs of heart valve disease. The researchers are also developing a machine learning algorithm which can detect signs of valve disease automatically. The results are reported in the IEEE Journal of Biomedical and Health Informatics.

Heart valve disease (valvular heart disease or VHD) has been called the ‘next cardiac epidemic,’ with a prognosis worse than many forms of cancer. Up to 50% of patients with significant VHD remain undiagnosed, and many patients only see their doctor when the disease has advanced and they are experiencing significant complications.

In the UK, the NHS and NICE have identified early detection of heart valve disease as a key goal, both to improve quality of life for patients, and to decrease costs.

An examination with a stethoscope, or auscultation, is the way that most diagnoses of heart valve disease are made. However, just 38% of patients who present to their GP with symptoms of valve disease receive an examination with a stethoscope.

“The symptoms of VHD can be easily confused with certain respiratory conditions, which is why so many patients don’t receive a stethoscope examination,” said Professor Anurag Agarwal from Cambridge’s Department of Engineering, who led the research. “However, the accuracy of stethoscope examination for diagnosing heart valve disease is fairly poor, and it requires a GP to conduct the examination.”

In addition, a stethoscope examination requires patients to partially undress, which is both time consuming in short GP appointments, and can be uncomfortable for patients, particularly for female patients in routine screening programmes.

The ‘gold standard’ for diagnosing heart valve disease is an echocardiogram, but this can only be done in a hospital and NHS waiting lists are extremely long – between six to nine months at many hospitals.

“To help get waiting lists down, and to make sure we’re diagnosing heart valve disease early enough that simple interventions can improve quality of life, we wanted to develop an alternative to a stethoscope that is easy to use as a screening tool,” said Agarwal.

Agarwal and his colleagues have developed a handheld device, about the diameter of a drinks coaster, that could be a solution. Their device can be used by any health professional to accurately record heart sounds, and can be used over clothes.

While a regular or electronic stethoscope has a single sensor, the Cambridge-developed device has six, meaning it is easier for the doctor or nurse – or even someone without any medical training – to get an accurate reading, simply because the surface area is so much bigger.

The device contains materials that can transmit vibration so that it can be used over clothes, which is particularly important when conducting community screening programmes to protect patient privacy. Between each of the six sensors is a gel that absorbs vibration, so the sensors don’t interfere with each other.

The researchers tested the device on healthy participants with different body shapes and sizes and recorded their heart sounds. Their next steps will be to test the device in a clinical setting on a variety of patients, against results from an echocardiogram.

In parallel with the development of the device, the researchers have developed a machine learning algorithm that can use the recorded heart sounds to detect signs of valve disease automatically. Early tests of the algorithm suggest that it outperforms GPs in detecting heart valve disease.  

“If successful, this device could become an affordable and scalable solution for heart health screening, especially in areas with limited medical resources,” said Agarwal.

The researchers say that the device could be a useful tool to triage patients who are waiting for an echocardiogram, so that those with signs of valve disease can be seen in a hospital sooner.

A patent has been filed on the device by Cambridge Enterprise, the University’s commercialisation arm. Anurag Agarwal is a Fellow of Emmanuel College, Cambridge.

Reference:
Andrew McDonald et al. ‘A flexible multi-sensor device enabling handheld sensing of heart sounds by untrained users.’ IEEE Journal of Biomedical and Health Informatics (2025). DOI: 10.1109/JBHI.2025.3551882



The text in this work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Images, including our videos, are Copyright ©University of Cambridge and licensors/contributors as identified. All rights reserved. We make our image and video content available in a number of ways – on our main website under its Terms and conditions, and on a range of channels including social media that permit your use and sharing of our content under their respective Terms.

source: cam.ac.uk